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Abstract 
 Formation of large fibers and plaques by amyloid proteins is recognized as the 
molecular hallmark of an increasing number of human disorders, including Parkinson's 
disease, Alzheimer's disease and even type II diabetes.  The broader objective of my 
research is to unravel the basic mechanisms that initiate and regulate fibril formation by 
amyloidogenic proteins.  This objective is significant because even basic aspects of how 
fibril formation proceeds from a soluble, monomeric protein to an insoluble amyloid 
fibril remain much debated.  Furthermore, there is increasingly strong evidence 
suggesting that intermediates of the aggregation process, with properties distinct from 
those of mature fibrils, are the aggregate species most toxic to human tissues.  Combining 
non-intrusive optical techniques (dynamic light scattering) to characterize the nucleation 
and growth kinetics of aggregation intermediates with high-resolution imaging (atomic 
force microscopy) to characterize aggregate morphologies and their physical dimensions, 
we have investigated the self-assembly process of two distinctly different amyloidogenic 
proteins – hen egg white lysozyme and human recombinant tau. 
 Initially, we used hen egg white lysozyme to characterize the kinetics and 
morphology of various intermediates emerging along a fixed assembly pathway.  We 
further investigated whether and how the fibril assembly process for lysozyme changed 
as function of salt concentration.  These experiments revealed that lysozyme displays 
three distinct types of aggregation behavior at different ionic strengths: monomeric fibril 
assembly, oligomeric fibril assembly, and amorphous precipitation.  We followed these 
 
 
x 
 
observations by exploring whether and how net intermolecular interactions among 
lysozyme monomers and the intramolecular conformation of lysozyme affect these 
transitions in the assembly process.   We found that the prevailing intermolecular 
interactions played dominant roles in regulating fibril assembly pathways, suggesting that 
protein interactions hold critical clues on how to control amyloid fibril assembly. 
 Using the same experimental approaches, we investigated the role of heat shock 
proteins as regulators of tau fibril assembly.  The native function of human tau is to 
stabilize the microtubules in the axonal processes of neurons.  The accumulation of 
aberrant tau into neurofibrillar tangles is diagnostic of many neurodegenerative diseases, 
including Alzheimer’s disease, frontotemporal dementia, and Pick’s disease.  A 
significant body of research indicates that phosphorylation, oxidation, and ubiquitination 
of human tau can impair its affinity for microtubules and trigger self-assembly of 
hyperphosphorylated tau into these neurofibrillar tangles.  Cells possess a large network 
of regulatory proteins called chaperones which are responsible for the proper folding and 
"disposal" of proteins, such as misfolded tau.   We therefore investigated the role of 
different chaperones on in vitro fibril assembly of tau.  We show that the small chaperone 
Hsp27, regardless of phosphorylation, is capable of inhibiting tau fibril growth in vitro.  
In contrast, dynamic phosphorylation and dephosphorylation of Hsp27 in vivo are 
necessary mechanisms for tau clearance and inhibition.   By defining these differences in 
tau aggregation under in vitro vs. in vivo conditions, we hope to gain better understanding 
on how the chaperone network interacts with tau and how to target various chaperones 
for therapeutic interventions. 
 
 
1 
 
 
 
 
 
 
Part I : Introduction and Background 
Chapter 1 
Introduction 
 Deposits of amyloid fibrils, insoluble protein fibrils with cross beta-sheet 
structure, are characteristic of numerous human disorders, including Alzheimer's disease, 
Parkinson's diseases and type II diabetes.  The broader objective of this dissertation is to 
elucidate the biophysical mechanisms regulating the self-assembly of amyloidogenic 
proteins into mature fibrils, for native as well as for intrinsically disordered proteins.  
Using a wide range of biophysical techniques, including dynamic and static light 
scattering, atomic force microscopy, and circular dichroism, I was able to investigate two 
structurally and functionally different amyloidogenic proteins, hen egg white lysozyme 
and human recombinant tau.  In Part I of this dissertation I will discuss the self-assembly 
behavior of lysozyme by characterizing different amyloid aggregation pathways and how 
intermolecular interactions may influence these assembly pathways.  In Part II of the 
dissertation, I will discuss the aggregation behavior of human recombinant tau and the 
role of chaperones as regulators of tau fibril assembly.  
     One major challenge towards understanding amyloid fibril self-assembly is to 
characterize the various intermediate aggregate structures emerging during fibril 
assembly and how this multitude of different structures relates to the formation of mature 
amyloid fibril.  One of the experimental challenges is the transient nature of these 
intermediate aggregate species, which interferes with efforts to isolate and characterize 
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them.  Various biophysical, biochemical or histopathological methods have been applied 
towards characterizing fibril assembly.  However, individual techniques provide only 
partial information such as molecular weight, hydrodynamic radius, overall morphology, 
or antibody reactivity.  Similarly, detailed structural analysis or characterization has often 
been limited only to the end stages of the aggregation process, at which point aggregation 
intermediates disappear or are severely depleted. In order to address these issues, we 
correlated noninvasive, in-situ dynamic light scattering (DLS) with atomic force 
microscopy (AFM) imaging.  Dynamic light scattering (DLS) is an in situ, non-invasive, 
label-free approach for obtaining a temporal record to the changes in particle size 
distribution associated with proteins undergoing fibril formation.  Atomic force 
microscopy (AFM), in turn, supplements these data with information about the detailed 
morphology and physical dimensions of the various intermediates formed during the 
fibril growth process. 
 
 In Part I of the dissertation we applied correlated DLS and AFM measurements to 
characterize the self-assembly of lysozyme into amyloid fibrils under acidic growth 
conditions.    In Chapter 3, we describe how we used this synergistic approach to obtain 
the kinetics for lysozyme fibrillogenesis and to detect all aggregation intermediates 
formed during self assembly.  We found that so-called oligomeric intermediates form the 
nucleus and building block for all subsequent aggregation structures, including mature 
fibrils.  These results are significant, because recent experiments have strongly implicated 
such oligomeric intermediates, transiently formed during fibril assembly, as dominant 
contributors to cellular toxicity in amyloid diseases.   
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 In Chapter 4, we investigated whether and how fibril assembly was affected by 
changes to the ionic strength of the growth solution.  This inquiry was motivated by the 
well-known effects of ionic strength on lysozyme crystallization and liquid-liquid phase 
separation.  Again, using correlated DLS and AFM measurements we found that changes 
in ionic strength induced sharp transitions in the aggregation behavior of lysozyme under 
fibril growth conditions.  Specifically, we found two distinct fibril assembly regimes 
which eventually gave way to amorphous precipitation at high salt concentrations. Each 
fibril assembly pathway was characterized by distinct populations of aggregation 
intermediates with different morphologies and different aggregation kinetics.  To explain 
our observations, we assessed whether these sharp transitions were related to changes in 
the intermolecular interactions among lysozyme molecules or could be explained by salt-
induced changes to the overall structure or thermal stability of the lysozyme monomers. 
  
 In Part II of the dissertation, we discuss our collaboration with Dr. Chad Dickey’s 
lab at USF Health regarding fibril formation of the intrinsically disordered protein, tau, 
and the ability of various chaperone proteins to alter tau aggregation.  Tau is a protein 
involved in stabilizing microtubules in the axonal processes of neurons. In its 
pathological form, tau dissociates from microtubules and forms neuronal tangles 
underlying multiple senile dementias, such as Pick’s disease and Alzheimer’s disease.   
The network of chaperone proteins, including many heat shock proteins (Hsp’s), 
facilitates protein folding and regulates protein degradation.  It has significant 
interactions with tau.   
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 In Chapter 5, we establish solution conditions for in vitro tau aggregation and 
assess the ability of a small heat shock protein called Hsp27 to modulate tau aggregation 
in vitro.  Specifically, we investigate the role of Hsp27 phosphorylation on tau 
aggregation.  Phosphorylation, an important regulatory mechanism which activates or 
deactivates many protein enzymes by causing conformational changes, assists in protein 
binding, signaling, and degradation.  Since Hsp27 becomes phosphorylated in response to 
stress, this mechanism may play a significant role in targeting Hsp27 and tau interactions.  
As a result, Hsp27 might represent an appealing target for developing novel therapeutic 
strategies that can target the chaperone network and promote clearance of abnormal tau. 
 In Chapter 6, we extended our observations to the effects of one of the most 
abundant proteins expressed cells, Hsp90 and its co-chaperone, FKBP51 on tau 
aggregation.  Given growing evidence that Hsp90 inhibition can reduce levels of 
aggregated tau and that co-chaperones of Hsp90 can also regulate tau levels, we 
investigated the in vitro interactions of two isoforms of Hsp90 and two FKBP51 
chaperones on tau aggregation.  We used dynamic light scattering and atomic force 
microscopy to compare the effectiveness of each chaperone’s ability to modulate tau 
aggregation. We also simulated the effects of known chaperone complexes in our in vitro 
assay by using combinations of Hsp90 and FKBP to identify which chaperone may play 
the dominant role during tau binding.   
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Chapter 2  
Background 
2.1 Hen Egg White Lysozyme: An Attractive Model Protein 
     We have investigated amyloid fibrillogenesis of the small globular enzyme, hen egg 
white lysozyme (HEWL).  Lysozyme has a molecular weight of 14,388 g/mol and 
consists of a single chain of 129 amino acids.  It’s biophysical and biochemical properties 
have been extensively characterized.  Upon incubation in acidic solutions below pH = 4 
and at elevated temperatures, native HEWL has been shown to grow amyloid fibrils [1].  
Commercial lysozyme stock can be prepared that is essentially devoid of pre-assembled 
aggregates which often interfere with nucleation and growth studies [2]. With variants of 
human lysozyme being implicated in hereditary systemic amyloidosis, HEWL provides 
an attractive and biomedically relevant model system for characterizing the transition of 
an ordered monomeric protein with a well-defined native structure to the amyloid fibril 
state with a distinctly different cross β-sheet structure [3]. 
 
 
 
 
Figure 2.1 Schematic of Transition from Lysozyme Monomer to Amyloid Fibril.  On the left is a 
solid ribbon representation of the native structure of lysozyme monomers.  Alpha-helices are 
shown in red; beta-strands are blue and irregular loops are grey [4].  To the right is a molecular 
model of an insulin fibril, considered representative of a typical amyloid fibril structure.  It 
consists of monomers of β-sheet structure stacked perpendicular to the fibril axis (cross- 
structure). [5] 
Lysozyme Monomer Amyloid Fibril 
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2.2 Tau Protein 
       Many neurodegenerative diseases are characterized by the abnormal aggregation of 
the protein tau into paired helical filaments forming neurofibrillary tangles in the brain.  
Tau is a highly soluble intrinsically disordered protein whose primary function is to 
stabilize microtubules in the axons of neurons. It consists of six isoforms characterized by 
their number of tubulin binding domains.  These isoforms have primary sequences 
ranging from 352-441 amino acids and consist of three-repeat binding domains or four-
repeat binding domains at the carboxyl-terminus with zero, one, or two inserts of 29 
amino acids at the N-terminus (Fig. 2.2) [6].  The isoform used for our studies was 4R0N 
with four-repeat binding domains, 383 amino acids, and a molecular weight of 40,007 
g/mol.   
 
 
Figure 2.2 Schematic of Tau domains and charge distribution.  Tau is divided into a projection 
domain located in the N-terminal region and a microtubule binding domain region (MTBD) in the 
C-terminal.  Tau has positive charges in the microtubule binding domain and part of the proline 
rich region for enhanced electrostatic binding to the negative charge of the microtubule.  Tau is a 
substrate of phosphorylation (P), glycosylation (G), and nitration (N) [7].   
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2.3 Dynamic Light Scattering (DLS) Theory 
      Dynamic Light Scattering is a non-invasive optical technique for quantifying the 
size of sub-micron particles by measuring the decay rate of fluctuations in scattering 
intensity caused by the particles Brownian motion.  In a typical experiment, a beam of 
light is passed through a suspension of particles which scatter light.  If the particles are 
small compared to the wavelength of light, the intensity of light is uniform in the plane 
perpendicular to the polarization of incident light and is termed Rayleigh scattering.  
However if the particles are large compared to the wavelength of light, the intensity is 
angle dependent or called Mie scattering.   
 
Figure 2.3 Schematic representation of scattering geometry. An incident, parallel beam of light 
(E0, k0) passes through a suspension of particles.  Light scattered from particles within the 
suspension is focused on the detector located at P and interferes there.  Here E0 is the incident 
electric field, k0 is the incident wave vector, k' is the wave vector for the scattered light, and q = 
k0 - k' is the scattering wave vector.  In a typical scattering set-up, k0 and k' are in the same plane 
and perpendicular to E0 [8]. 
       
 For incident light that is coherent and monochromatic (such as a laser) it is 
possible to analyze the time-dependent fluctuations in the scattered intensity by using a 
photomultiplier and recording the number of scattered photons.  The particles undergoing 
thermally driven Brownian motion cause rapid fluctuations between constructive and 
destructive interference of the coherently scattered light at the detector location P.  By 
 
 
9 
 
analyzing the time dependence of these intensity fluctuations, the diffusion coefficient of 
the particle and the hydrodynamic radius can be determined [9, 10, 11].  
      To analyze the time dependence of the noisy intensity fluctuation, the intensity 
autocorrelation function, [10] 
        
 
dttItI
dttItI
g2                                               (2.1) 
 is used. 
 The intensity-intensity correlation function provides the distribution of relaxation 
times for the various particles diffusing in solution.  This distribution of exponential 
decays of the correlation function can be inverted to obtain the the size and polydispersity 
of the various populations. 
      In order to obtain these particle size distributions, the experimentally measured 
intensity correlation function is first converted into the field correlation g1(τ) via the 
Siegert relationship [9,11,12]: 
  1g)(g 21       (2.2) 
 For a collection of small particles, it can be shown that g1(τ) is the sum of 
exponential decay rates given by:  
g1(τ) = Σ exp(-Dq2τ)                                                   (2.3) 
where D is the translational diffusion coefficient for a particle of given size and shape 
and q is the scattering wave vector.  The scattering wave vector is given by: 
q = (4πn/λo) sin(θ/2)                                                  (2.4) 
where n is the refractive index of the scattering medium, λo is the wavelength of incident 
light in vacuum, and θ is the angle of scattering (See Fig. 2.3).   
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 Finally, from the translation diffusion coefficient, D, the hydrodynamic radius for 
a spherical particle can be calculated from the Stokes-Einstein equation,  
Rh = kBT/6πηD                                                   (2.5) 
where kB is the Boltzman constant, T is the absolute temperature, and η is the viscosity of 
the solution [12,13].   
 The typical decay times sampled in experiments can range from a few hundred 
nanoseconds to several seconds, depending upon the particle size and viscosity of the 
medium.  The size accessible to dynamic light scattering range from nanometers to a few 
microns in diameter.  The lower limit of the particle size is highly dependent on the 
scattering properties of the particles concerned, the suspending medium, the incident light 
intensity, and the detector.    For instance, the Malvern Zetasizer Nano, quotes a lower 
limit of 0.6 nm and an upper limit equal to 6 microns.    
 
Figure 2.4 Diagram of Dynamic Light Scattering Set-up from Malvern Instruments.  As the laser 
illuminates the sample, scattered light is measured by the detector at a specified angle and passed 
to the digital correlator for processing by software algorithms to calculate the size and 
polydispersity of the suspension of particles. [14] 
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2.4 Static Light Scattering (SLS) Theory 
Static light scattering from macromolecules measures the time-averaged intensity 
of scattering light due to the thermally induced fluctuations in their local concentrations.  
The scattering intensity caused by the protein is given by [15] 
)q(S)q(P
dc
dn
NR
Mcn4
I
I
2
pA
24
p
22
i
s 




                                 (2.6) 
where n is the solvent refractive index, M is the molecular weight of the solute (protein), 
dn/dcp is the refractive index increment of the solution due to the protein, cp is the 
protein’s mass density, NA is Avogadro’s constant, R is the distance between the origin of 
the scattering volume and the detector, and  is the wavelength of the incident light. P (q) 
and S (q) are the form and static structure factor, which account for intraparticle and 
interparticle interference respectively, and q is the scattering wave introduced in Equation 
(2.4). 
 Since lysozyme’s radius (a~2nm) is much smaller than the wavelength of incident 
light (λ = 632nm), the angular dependence of the scattering intensity is negligible and 
P(q)  ≈ 1.    Additionally, for typical experimental conditions the mean spacing between 
lysozyme molecules is much less than the wavelength of the light.  As a result our 
solutions falls within the so-called long wavelength, or q ≈ 0, limit.  In this limit the 
structure factor S (q≈0) can be approximated by a virial expansion in the solute 
concentration and the corresponding scattering intensity becomes [15] 
 ........cB3cB2MNR
dc
dncn4
I
I
2
p3p2
1
A
24
2
p
p
22
i
s





                                 (2.7) 
Defining the optical constant, K, as [15] 
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2
p
4
A
2
dc
dn
N
n4
K 




                                                    (2.8) 
and the Rayleigh ratio Rθ  by 
2
i
s R
I
I
R                                                          (2.9) 
The Rayleigh Equation, to the lowest approximation can be written as [15] 
  p2sp cB2M
1k1
M
1
R
KC 

                                 (2.10) 
where M is the molecular weight of the protein, Cp is the protein concentration (in 
mg/mL), ks is the direct interaction parameter, ϕ = νCp is the protein volume fraction, and 
B2 is second virial coefficient.  For lysozyme ν = 0.703 mL/g [12]. 
 In practice, a reference standard such as toluene is used to define the Rayleigh 
ratio via [12]  
T2
TT
2
oS R
nI
nIR   
where ∆Is is the difference of the scattering intensity of the solution with solute vs. 
without dissolved solute, IT is the toluene scattering intensity, no is the solvent refractive 
index, nT is the toluene refractive index, and RT is the Rayleigh ratio for toluene.  A plot 
of KCp/R vs. protein concentration varies linearly with protein concentration.  The 
molecular weight of the protein can be derived from the y-intercept at Cp=0 and the 
second virial coefficient B2 equals the slope. Positive values of B2 indicate net repulsion 
whereas negative values of B2 indicate net attraction between proteins [12,13,15].              
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2.5 Atomic Force Microscopy Background 
 The atomic force microscope (AFM) is a mechanical imaging device capable of 
measuring the three dimensional topography of surfaces down to fractions of nanometers.   
The AFM consists of a sharpened probe or tip usually made of silicon on the end of a 
cantilever.  The silicon tip is used to scan the surface of a sample by measuring the forces 
between the sample and tip.  As the tip approaches the surface, the forces between the tip 
and sample lead to a deflection of the cantilever which is measured by using a laser spot 
reflected from the top of the cantilever to a quadrant photodiode.  The electronic output 
of the quadrant photodiode is then sent to a feedback controller that drives a Z motion 
generator to maintain a constant force or distance between the tip and sample surface.   
AFM imaging methods can be divided into static (contact) modes and dynamic 
(non-contact) modes.  In contact mode, the deflection or force between the tip and sample 
is kept constant by adjustments in the z direction from the feedback mechanism. The 
voltage that the feedback amplifier applies to the piezo to raise or lower the sample is a 
measurement of the height of the sample’s features as a function of the lateral position.  
Contact mode is usually chosen for hard or rough samples where lateral forces will not 
damage the sample due to scraping across the surface. 
For biological or soft samples, non-contact modes or AC modes are used by 
oscillating the cantilever near its resonance frequency without constant contact with the 
sample.  The changes in the oscillating frequency or the amplitude of the cantilever 
provide the signal for imaging.  For instance, in tapping mode the amplitude of the 
cantilever’s oscillation decreases as the tip gets closer to the surface extending into the 
repulsive regime where the tip intermittently touches the surface. 
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Figure 2.5 Diagram of Atomic Force Microscope. As the cantilever approaches the surface, the 
cantilever bends, changing the light path of the laser reflected from the top of the cantilever to the 
photodetector. [16] 
 
2.6 Circular Dichroism 
 Circular dichroism (CD) refers to the difference in absorption of left vs. right-
handed components of circularly polarized light due to the preferential absorption by 
asymmetric or chiral molecules.  CD is a powerful tool to measure the content of tertiary 
and secondary structures of proteins.  Absorption in the far UV range (190-250 nm) is 
primarily due to the peptide backbone of the protein resulting in absorptions at 
characteristic wavelengths for different secondary structures.  For example, alpha-helical 
proteins have negative bands at 222nm and 208nm, beta-sheets have negative bands at 
218nm, and disordered proteins have negative bands near 195nm.  Comparing sample 
spectra to known reference spectra, estimates of the types of secondary structure for an 
unknown protein can be obtained [17,18].  
 
 
 
 
Figure 2.6 Far UV CD spectra associated with various 
types of secondary structure.  Solid line, a-helix; long 
dashed line, anti-parallel β-sheet; dotted line, type I β-
turn; cross dashed line, extended 310-helix or poly (Pro) 
II helix; short dashed line, irregular structure. [17] 
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Part II : Lysozyme Self Assembly Behavior and Lysozyme Interactions 
Chapter 3 
Protofibrils of Lysozyme Nucleate and Grow Via Oligomer Fusion 
 
3.1 Introduction 
     Alzheimer’s disease and Parkinson’s disease are two familiar representatives of 
an entire category of human disorders called amyloidoses. Amyloidoses are characterized 
by the deposition of protein plaques in the extracellular matrix or intracellular deposits 
(neurofibrillar tangles and inclusion bodies) associated with extensive tissue damage in 
the immediate vicinity of these deposits [1,2]. The protein fibrils forming the scaffold for 
these deposits all share a common cross-β-sheet architecture [3,4] that has little 
correlation with the native structure of the various proteins or proteolytic fragments that 
form these protein fibrils (see Fig. 2.1). Recent studies have implicated intermediate 
aggregates formed transiently during the assembly of mature fibrils, and not the 
prominent protein plaques, as the molecular species causing most cellular toxicity in 
amyloidoses [5,6]. Hence, understanding the process of amyloid self-assembly into 
mature fibrils not only represents a basic challenge in protein science, but is critical for 
unraveling the causes of cell death associated with amyloidoses. 
 Several distinct aggregate species were clearly identified as intermediates during 
amyloid fibril growth, including small oligomeric species, protofibrils, and mature fibrils 
[7]. The latter represent the basic building block of large polymer bundles forming 
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protein plaques [7,8]. One contentious and actively pursued question in amyloid fibril 
growth concerns whether transient aggregates such as oligomers and protofibrils 
represent essential on-pathway precursors toward mature fibril assembly [9,10] or off 
pathway alternatives to mature fibrils [11], or whether multiple competing aggregation 
pathways converge towards the shared structure of mature fibrils [12,13]. Part of the 
difficulty in answering these questions is intrinsic to the very nature of intermediate 
aggregates: they represent metastable and transient states that are in dynamic exchange 
with their monomeric background [14]. These difficulties are aggravated by the 
sensitivity of aggregates sizes and morphologies to subtle manipulations in solution 
conditions or sample preparation [15,16]. As a result, a noninvasive and quantitative 
characterization of the intrinsic growth kinetics, sizes, and morphologies of different 
soluble amyloid intermediates represents an important step toward unraveling the elusive 
relationship between different types of intermediate aggregates and their role in amyloid 
fibril self-assembly. 
 We have combined in situ dynamic light scattering (DLS) with off-line atomic 
force microscopy (AFM) for investigating the amyloid fibrillogenesis of hen egg-white 
lysozyme (HEWL). Lysozyme is a small globular enzyme and is often used as a model 
system for studying amyloid fibril formation [17–19]. Variants of human lysozyme are 
implicated in occurrences of hereditary systemic amyloidosis [20]. Upon incubation in 
acid solutions below pH 4 and at elevated temperatures, native HEWL will grow amyloid 
fibrils in vitro [21]. Commercial lysozyme stock can be prepared that is essentially 
devoid of any preassembled aggregates which could otherwise interfere with intrinsic 
nucleation and growth behavior [22].  Therefore, HEWL represents an attractive and 
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biomedically relevant model system for characterizing intermediate amyloid species, and 
for investigating aggregation pathways [17].   
 We place strong emphasis on tight, quantitative correlations between the results 
obtained with DLS and AFM measurements. DLS distinguishes itself from alternative 
characterization techniques because it is essentially noninvasive, is highly sensitive in 
detecting even small fractions of aggregated material, and provides an in situ readout of 
particle distributions and their respective growth kinetics [23]. These significant 
advantages of DLS are mitigated by its limited ability to resolve aggregates whose 
hydrodynamic radii Rh differ by less than a factor of 2 or 3. AFM, in contrast, provides 
direct images of aggregate morphology and quantitative measurements of aggregate 
heights. Using AFM, however, can be problematic because surface deposition has the 
potential to alter the very aggregate structures one is trying to characterize [16]. In 
addition, one has to correct for the dilation of lateral aggregate dimension by the finite-
sized scanning tip in order to obtain physical aggregate dimensions.   
 To address these shortcomings, we calibrated AFM scanning tips, obtaining not 
just images of aggregate morphologies but quantitative measurements of vertical and 
lateral aggregate dimensions. Some of the simpler aggregate geometries characterized 
using AFM were compared against the diffusion constants derived from in situ DLS 
measurements. As a result, we were able to make specific statements regarding the 
geometries, physical dimensions, assembly pathways, and nucleation and growth kinetics 
of lysozyme oligomers and protofibrils emerging during amyloid fibril growth. 
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3.2. Materials and Methods 
3.2.1 Proteins and Chemicals 
        For all experiments, 2x recrystallized, dialyzed, and lyophilized lysozyme from 
Worthington Biochemicals (Lakewood, NJ) was used. All other chemicals were from 
Fisher Scientific (Pittsburgh, PA), and were reagent grade or better. We used 18 MW 
distilled water (Barnstead E-pure, Dubuque, IA) throughout. 
3.2.2 Preparation of HEWL Amyloid Fibrils 
 Solutions of lysozyme (17 mg/mL) at pH 2.0 with 175 mM NaCl were prepared 
by dissolving lyophilized lysozyme in distilled water at twice its final concentration, and 
mixing it 1:1 with a NaCl/water solution, also at twice its final concentration. Before 
mixing, lysozyme solutions were warmed to 45ºC to remove any preformed clusters. All 
samples were centrifuged at 9,500 x g for 5 min, and filtered consecutively through a 
220-nm and a 20-nm pore-size syringe filter. Solution pH was readjusted to pH 2.0 with 1 
N HCl. Lysozyme concentrations in solution were determined from ultraviolet absorption 
measured at λ = 280 nm (a280 = 2.64 mL mg-1 cm-1) [24]. Lysozyme solutions incubated 
for 4–5 days at 50ºC started to form a soft gel. Fibers taken from the gelled-out samples 
induced a red shift in the absorption spectrum of Congo red, a feature diagnostic of the 
formation of mature amyloid fibrils. Samples analyzed prior to 3 days of incubation 
showed spectral shifts identical in magnitude to the nonspecific shift induced by 
lysozyme monomers before incubation (data not shown). 
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3.2.3 Dynamic Light Scattering during Amyloid Aggregation 
 DLS measurements were performed with a Zetasizer Nano S (Malvern 
Instruments, Worchestershire, UK) containing a 4-mW He-Ne laser (λ = 633 nm) and 
with built-in temperature control for sample cuvettes. After thermal equilibration of the 
samples (typically < 5 min), autocorrelation functions were collected every 10 min, using 
acquisition times of 60 s. Autocorrelation functions were converted into particle-size 
distributions, using the ‘‘narrow modes’’ algorithm provided with the Zetasizer Nano S. 
Particle-size distributions obtained from alternative inversion algorithms yielded 
comparable results.  
3.2.4 Atomic Force Microscopy of Amyloid Aggregates 
 Amyloid samples were imaged with an MFP-3D atomic-force microscope 
(Asylum Research, Santa Barbara, CA) using NSC36/NoAl (Mikromasch,San Jose, CA) 
or PFP-FMR-50 (Nanosensor, Neuchatel, Switzerland) silicon tips with nominal tip radii 
of 10 nm and 7 nm, respectively. The cantilever was driven at 60–70 kHz in alternating 
current mode and at a scan rate of 0.5 Hz, acquiring images at 1024 x 1024-pixel 
resolution. Raw image data were corrected for image bow and slope.  
 During DLS measurements of amyloid fibrillogenesis, 10-μL aliquots of solution 
were taken from the DLS cuvette for subsequent AFM imaging. Aliquots were diluted 
100-fold with 175 mM NaCl/pH 2.0 salt solutions. Typically, 75 μL of solution was 
deposited on freshly cleaved mica for 5 min, rinsed with deionized water, and dried with 
dry nitrogen. Images of monomers required significantly longer deposition periods (≥15 
min), apparently because their surface affinity and/or deposition kinetics onto mica are 
significantly lower than those of higher-order aggregates. These differences presumably 
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account for the apparent lack of monomers and/or oligomers in AFM images taken after 
protofibril formation. Images of amyloid aggregates were acquired in air. Using DLS, we 
confirmed that cooling the lysozyme samples from 50ºC to room temperature essentially 
arrested aggregation (data not shown). Hence, AFM images faithfully represented the 
aggregate distribution at the time of aliquot collection. 
3.2.5 AFM Tip Calibration and Correction for Tip Dilation 
 AFM scanning tip radii were determined by imaging 5-nm gold colloid standards 
(catalogue No. GC5; BBI International, Cardiff, UK). Poly-d-lysine (1%) was deposited 
onto freshly cleaved mica for 10 s, rinsed with deionized water, and dried with nitrogen. 
Gold colloids were diluted 1:20 with deionized water and deposited for 5 min, rinsed 
with deionized water, and dried with nitrogen. As indicated in Fig. 3.1, the apparent 
width Wapp of an incompressible object imaged with an AFM tip is considerably larger 
than its physical width W.  
 
Figure 3.1 Dilation of lateral particle dimension during 
AFM imaging. Finite size of AFM scanning tips (shown 
here as parabola) increases apparent width Wapp of 
particles well beyond their actual width W. For an 
ellipse, W can be derived using the measured height H 
and Wapp of the particle as well as the tip radius Rtip [25]. 
  
  
 Apparent width Wapp and height for a given gold colloid were determined from 
individual scan lines across the maximal height of a given gold colloid. Following Taatjes 
et al. [25], the apparent width Wapp and height of a sphere were used to obtain the radius 
Rtip of the scanning tip. Based on variations in the measured heights of the colloidal gold 
standards, the radii of individual gold colloids will vary slightly. Therefore, we 
determined the radius Rtip using a series of gold colloids (Figure 3.2). This approach 
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yielded reproducible and self-consistent values for Rtip. Repeating tip calibrations during 
extended imaging sessions on mica substrates indicated that tip radii remained unaltered.  
 To correct for the dilation in apparent particle width induced by scanning tips 
(Fig. 3.1), line profiles of the apparent particle width versus height were taken across the 
center of a given particle. The direction for these line profiles was typically chosen as 
perpendicular to the scanning direction of the AFM tip during image acquisition. The 
shape of profiles was nearly symmetric around the peak height, suggesting that 
mechanical tip distortions were small. Assuming that aggregates had ellipsoidal cross 
sections and using the AFM tip radius determined during tip calibration, the actual 
particle width was calculated [25]. 
 
Figure 3.2 Calibration of AFM Tip Radius Using Colloidal Gold Standards. (A) AFM image of 5 
nm gold colloids deposited on mica. (B) Height vs. position profile across the center of a single 
gold colloid which yield the apparent width Wapp and height for a colloidal gold sphere. (C) Tip 
radii Rtip obtained for several gold colloids with slightly different diameters. As indicated, the tip 
radius was independent of the specific diameter of the gold colloid used for calibration. 
3.2.6 Prediction of Hydrodynamic Radii from AFM Particle Dimensions 
 Particle dimensions for lysozyme monomers and oligomers were extracted from 
AFM line scans. The formula of Perrin [26] predicts the hydrodynamic radius for a 
sphere diffusing at the same rate. For an oblate ellipsoid with major axis a and minor axis 
b, the hydrodynamic radius is given by Perrin [26] as: 
Rh = b x / tan-1(x), where x= [(a/b)2-1]1/2 
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 Similarly, the straight protofibrils present shortly after nucleation were 
approximated as cylindrical rods. The effective hydrodynamic radius for a cylinder of 
length L and diameter d is given by 
Rh = L/2 [(1-x2)1/2 / ln(1+(1-x2)1/2/ x)],  
where x = d/L [ 1 + 0.37(L-d)/L] 
3.3 Results 
3.3.1 In situ DLS Measurements of Aggregate Distributions and Growth Kinetics 
 
Figure 3.3 Kinetics of fibril formation by HEWL, monitored in situ with DLS. (A) Temporal 
evolution of field autocorrelation functions g1(τ) of light scattered from HEWL solutions during 
amyloid fibrillogenesis at pH 2.0 and T = 50°C. After a latency period of ~10 h, a prominent 
shoulder of slower decay rates emerges in correlation functions. (B) Semi-log plot of particle size 
distributions (PSDs) derived from correlation functions in A. Initially, the PSD has a single, 
narrow, ‘‘small-aggregate’’ peak. After a lag period of several hours, a second ‘‘large-aggregate’’ 
peak emerges and starts to dominate PSDs. (C) Log-log plot of center position of two aggregate 
peaks in B as a function of incubation period. Note nucleation and gradual growth of larger 
aggregate peak. (D) Log-log plot of changes in static scattering intensity Iscat versus incubation 
period. Intensity values were corrected for changes in laser attenuation used to avoid detector 
saturation. 
 
 
25 
 
 DLS is a minimally invasive technique for detecting and characterizing submicron 
aggregates in situ with high temporal resolution. This is a distinct advantage when trying 
to resolve the growth kinetics of multiple aggregate species that are in dynamic exchange 
with one another. Fig. 3.3 A shows the temporal evolution of the field autocorrelation 
functions g1(τ) of light scattered during the fibril formation of HEWL at pH 2.0 over a 
period of 4 days. After a nearly single-exponential decay of g1(τ) for DLS measurements 
during the initial 10 h of incubation, g1(τ) suddenly develops a prominent shoulder. This 
shoulder indicates the formation of a second population of larger aggregates, 
characterized by slower diffusion coefficients. The increasing amplitude of this shoulder 
and its steadily decreasing decay rate suggest that both the sizes and numbers of these 
larger aggregates are increasing in time.   
 Particle size distributions (PSDs) were derived from the measured correlation 
function by analyzing their underlying distribution of decay rates (detailed in Section 
2.3). These PSDs contained, at most, two aggregate peaks with well-separated 
hydrodynamic radii, which we refer to as ‘‘small-aggregate’’ and ‘‘large-aggregate’’ 
peaks (Fig. 3.3 B). During initial stages of incubation, the small-aggregate peak, with a 
distribution centered near a hydrodynamic radius Rh of 2 nm, was dominant. The larger-
aggregate species emerged after a sample-specific latency period of several hours, with 
an initial Rh near 25 nm. After the appearance of the large-aggregate peak, the small-
aggregate peak began to fade slowly. Fig. 3.3 C shows the temporal evolution of the 
mean radius for either of these two aggregate populations. The mean radius of the small 
aggregate peak appears to be essentially stationary, whereas larger aggregates increase 
their mean radius slowly but steadily over the course of 2 days. Fig. 3.3 D displays the 
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corresponding changes in static scattering intensity as a function of time. The nucleation 
event of the large-aggregate peak seen in Fig. 3.3 C leads to an accelerating growth in 
scattering intensity. At the end of the 4-day period, the total scattering intensity has 
increased nearly 100-fold above its value at the beginning of the experiment. This latter 
observation has two implications. First, one must be careful interpreting the apparent 
‘‘loss’’ of small aggregates from the particle-size distribution observed after about 2 days 
of incubation (Fig. 3.3, B and C). This loss is attributable, at least in part, to the rapid rise 
in scattering signal from the larger aggregates, which overwhelms residual scattering 
contributions from smaller aggregates. Second, the nearly 100-fold increase in scattering 
intensity (Fig. 3.3 D) is in marked contrast to the very modest twofold increase in mean 
hydrodynamic radius of the large-aggregate species over the same 2–3 days (Fig. 3.3 C). 
This behavior puts significant constraints on any kinetic model of aggregate growth in 
this system. 
 Aside from the expected variations in the latency period of nucleation, all of the 
above features of DLS data were remarkably reproducible (Ntotal = 12), indicating that 
they capture the intrinsic behavior of lysozyme amyloid growth in acidic solutions. The 
observed evolution of PSDs and corresponding changes in scattering intensity provide 
detailed information about the kinetics of aggregate nucleation and growth.  However, the 
DLS data also contain several ambiguities that prevented a more detailed analysis. In 
particular, it was unclear whether either the small-aggregate or large-aggregate peaks in 
Fig. 3.3 B were composed of multiple distinct aggregate species not resolved into 
separate components by DLS. In addition, the identity of intermediate aggregates 
undergoing nucleation from solution remained uncertain. Finally, no specific information 
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was provided about the morphology of any of the intermediate aggregate species 
comprising either aggregate peak. To address these shortcomings, we performed offline 
AFM on samples undergoing fibril formation.   
3.3.2 Offline AFM Measurements of Aggregate Morphologies and Their Dimensions 
 To correlate AFM data with DLS measurements, lysozyme fibrillogenesis was 
monitored using DLS while small aliquots were withdrawn for AFM imaging at various 
times during the incubation period. Before AFM measurements, the radii of all AFM 
scanning tips were calibrated against colloidal gold standards. As detailed in Section 
3.2.5, this enabled us to derive not just aggregate height distributions, but also lateral 
aggregate dimensions.   
 The AFM images of lysozyme before heating yielded uniform particles well 
approximated by oblate ellipsoids, with dimensions of 3.0 ± 0.2 nm in height and 3.8 ± 
0.8 nm in equatorial width (Fig. 3.4 A and Table 3.1). Because their volume of 22.6 nm3 
is in close agreement with the volume of 21.2 nm3 for lysozyme monomers in crystals 
(27), we identified these particles as lysozyme monomers. The aspect ratio of surface-
absorbed lysozyme monomers was slightly different from that of their counterparts in 
solution [28]. After raising sample temperatures to 50°C, solutions contained mixtures of 
lysozyme monomers and compact elliptical aggregates with narrow size distributions 
(Fig. 3.4 B). We refer to these small, compact aggregates as oligomers. Our AFM 
observations thus imply that the seemingly uniform small aggregate peak observed with 
DLS was indeed composed of lysozyme monomers, combined with an increasing number 
of oligomers that formed upon sample heating. Oligomer dimensions, determined by 
AFM at different times, remained constant. The ratios of apparent widths versus heights 
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obtained using AFM were not consistent with the assumption of a spherical geometry for 
either oligomers or monomers, but did match those expected for oblate ellipsoids. Based 
on this ellipsoidal geometry, the volume of oligomers was estimated at 8.1 times that of a 
lysozyme monomer, suggesting that oligomers are composed of eight monomers.  
 
Figure 3.4 Evolution of aggregate morphologies for lysozyme amyloid growth at 175mM NaCl, 
pH 2.0, and T = 50°C. (A) Before heating (T = 20°C), a uniform population of HEWL monomers 
is present. (B) AFM images of HEWL samples after 3 h of incubation at 50°C predominately 
yield oligomers. (C) AFM image of protofibrils appearing ~10 h, i.e., shortly after nucleation 
event seen in DLS. (D) AFM image of protofibrils after 25 h of incubation. (E) AFM image of 
long, straight fibrils formed after ~100 h of incubation, against a background of protofibrils (note 
change in scale-bar). Below each image is the distribution of aggregate heights and lateral 
aggregate widths (the latter corrected for AFM tip distortions). Differences in oligomer size in the 
images in B versus protofibril images in C highlight AFM tip contributions to the apparent lateral 
aggregate dimensions (16 nm in A and B versus 12.5 nm in C–E). Tip-corrected aggregate 
dimensions are identical (see Fig. 3.6 and Table 3.1). 
 
 The prominent nucleation of larger aggregates detected by DLS (Fig. 3.3 C) 
coincides with the appearance of short, cylindrical polymers in AFM images (Fig. 3.4 C). 
We identify this polymeric species as protofibrils, consistent with previous AFM 
assignments of intermediate aggregate morphologies observed with beta-amyloid (Aβ)1-40 
[29]. During the 2–3 day growth period after nucleation, the contour length of protofibrils 
increases significantly (Fig. 3.4 D). The increase in protofibril contour length goes hand-
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in-hand with a significant increase in the curvature of protofibril strands. This transition 
from straight to highly curved morphologies is particularly apparent when comparing 
late-stage protofibril shapes (Fig. 3.4, D and E) with the short, straight protofibrils 
present shortly after nucleation (Fig. 3.4 C).  
 
Table 3.1 Heights and actual widths of amyloid aggregates at 175mM NaCl, pH = 2.0, and T = 
50°C.  
 
 
 
 
Figure 3.5 Dimensions of intermediate amyloid aggregates. Summary of heights and widths of 
lysozyme monomers, oligomers, protofibrils, and mature fibrils obtained from AFM images after 
tip correction. Ellipses displayed above are scale representations of measured cross sections. 
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 The AFM images of protofibrils reveal several intriguing features. First of all, 
protofibrils have noticeable and rather regular height undulations. In principle, this 
variegated appearance is compatible with the presumption that any polymeric precursor 
of mature fibrils already displays the helical twists known to exist in mature fibrils (3). 
However, our calibrated AFM measurements of aggregate dimensions indicate that 
protofibril heights and width are identical to those of oligomers seen before protofibril 
nucleation (Table 3.1 and Fig. 3.5). Fig. 3.6 compares the three-dimensional profile of an 
oligomer versus the corresponding appearance of a short protofibril, both visualized with 
AFM using identical scanning tips. The height undulations (Fig. 3.6 B), combined with 
the tight agreement of the protofibril cross section with the overall height and width of 
oligomers (Figs. 3.5 and 3.6), indicate that protofibrils are composed of oligomers. The 
appearance of well-distinguished ‘‘blobs’’ with dimensions comparable to those of 
oligomers suggests how oligomers coalesce to form protofibrils: oligomers fuse along 
their high-curvature perimeter, forming strings of aggregates similar to hockey pucks 
lining up edge to edge on a flat surface. 
During the late stages of our experiments, a second, distinct population of fibers 
emerged. These mature fibrils are much longer and stiffer than those of the shorter 
protofibrils (Fig. 3.4 E). A direct comparison of mature fibril cross sections with those of 
protofibrils (Fig. 3.5) indicates that the former have a cross sectional area close to twice 
that of a protofibril.  Both the radius of curvature of mature fibrils and their overall length 
are dramatically increased over those of protofibrils (Fig. 3.4 E). This dramatic increase 
in persistence length indicates that mature fibrils are mechanically much stiffer than 
protofibrils. Although we did not analyze this feature quantitatively, it is again in good 
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qualitative agreement with AFM images of Aβ1-40 protofibrils versus mature fibrils (e.g., 
Fig. 1 in Koo et al. [29]). Distributions of aggregate heights and actual widths (corrected 
for AFM tip dilation) of all intermediate amyloid aggregates are summarized in Fig. 3.5 
and Table 3.1. 
 
Figure 3.6 AFM surface topography of oligomers and protofibrils. (A) AFM topography of a 
HEWL oligomer after 3 h of incubation at 50º C. (B) AFM topography of HEWL protofibrils 
shortly after nucleation event. Both images were collected with the same scanning tip.  Images 
are 125 nm on a side. 
 
3.3.3 Quantitative Comparison of DLS with AFM Aggregate Dimensions 
 As alluded to in the Introduction, any offline analysis of intermediate amyloid 
aggregates carries the potential risk of disrupting some of the aggregate features it is 
intended to characterize. With AFM, the morphology of amyloid aggregates can depend 
on the properties of the substrate used for deposition or growth [16]. It is also not obvious 
whether the sizes and shapes of amyloid aggregates in solution should match those that 
were dried and deposited on mica substrates. We therefore tested whether aggregate 
shapes and sizes obtained from offline AFM scans with calibrated tip sizes were 
consistent with corresponding hydrodynamic radii obtained from in situ DLS. For 
comparisons of particle dimension we chose monomers, oligomers, and early-stage 
protofibrils. Monomers and oligomers were suitable, because their shapes can be closely 
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approximated by oblate ellipsoids, and their sizes did not change over time.  Similarly, 
the geometry of early-stage protofibrils (Fig. 3.4 C) was well represented by cylindrical 
rods with an initial length of 125 ± 28 nm and a diameter of ~6 nm. Using Perrin’s 
formulas (see Section 3.2.6 and Perrin [30]) allowed us to calculate the hydrodynamic 
radius, Rh for the equivalent sphere with the same (translational) diffusion constant as an 
oblate ellipsoid or a long, thin cylinder.  
 
Table 3.2 Comparison of measured (DLS) and estimated (AFM) hydrodynamic radii of 
intermediate aggregates 
 
 
DLS Rh (nm) - measured hydrodynamic radii for lysozyme monomers (0 h), weighted averages of 
monomers and oligomers (3 h), and protofibrils shortly after nucleation (10.5 h). AFM Rh (nm) - 
predicted hydrodynamic radii for lysozyme monomers, oligomers, and protofibrils based on AFM 
dimensions. *DLS ‘‘oligomer radius’’ is average of monomers and oligomer radius, weighted by 
scattering intensity for each species present at 3 h. 
 
Table 3.2 summarizes these equivalent hydrodynamic radii for lysozyme 
monomers, oligomers, and initially rod-like protofibrils, as predicted from their dry-
aggregate dimensions (AFM) versus measured average hydrodynamic radii (DLS). Given 
our simplifying assumptions about particle geometry, the neglect of hydration layers, and 
the potential for particle distortions from AFM tips and/or surface adhesion, the 
hydrodynamic radii of monomers and protofibrils predicted from AFM measurements 
matched surprisingly well with measured DLS radii for either population. The DLS 
radius for oligomers deserves further comment. The less than twofold difference in 
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hydrodynamic radii for oligomers versus monomers, as predicted by AFM, is below the 
resolution limit typical for DLS.  Hence DLS could not separate the small aggregate peak 
into its two components. The ‘‘oligomer’’ radius reported in Table 3.2 is really the 
average of monomers and oligomers, weighted by their respective scattering intensities. 
This interpretation is also supported by subtle changes to the shape of the ‘‘small-
aggregate peak’’ during the early stages of nucleation (Fig. 3.7 A). As time passes, the 
narrow peak in the particle size distribution progressively broadens with time, because of 
the formation of an increasing number of oligomers.  
The above analysis indicates that, whenever a direct comparison was feasible, the 
dimensions of intermediate aggregates derived from calibrated AFM measurements were 
consistent with corresponding in situ measurements obtained with DLS. Hence, we felt 
assured that conclusions about aggregate morphologies and dimensions derived from 
offline AFM observations accurately represented the in situ behavior of aggregates 
during growth in solution.  Conversely, we used our a priori knowledge of aggregate 
morphologies derived from AFM imaging to reduce the ambiguities intrinsic to the 
inversion of DLS decay rates into particle-size distributions. Specifically, AFM indicates 
that, before protofibril nucleation, the solutions are mixtures of monomers and oligomers, 
each with fixed hydrodynamic radii. Therefore, we directly fit the field correlation 
functions g1(τ) to double exponentials, with decay rates set to the predetermined 
monomer and oligomer radii. Residual errors for this double-exponential fit (without 
adjustable parameters) were significantly reduced over comparable fits to single 
exponentials with adjustable decay rates. Using this approach, we found that the mean 
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hydrodynamic radius <Rh> increases linearly during the first 3 h of oligomer growth (Fig. 
3.7 B). Thus the rate of oligomer formation during the lag phase is essentially constant. 
 
 
 
 
 
Figure 3.7 Analysis of oligomer formation 
in DLS. (A) Shape of ‘‘small aggregate 
peak’’ before protofibril nucleation 
becomes increasingly skewed, with its 
center position shifting slightly. These 
changes coincide with growth of uniformly 
sized oligomers seen in AFM (Fig. 3.4 B). 
(B) Changes in mean hydrodynamic radius 
<Rh> obtained from double-exponential fits 
to DLS autocorrelation functions during 
initial 3 hr of oligomer growth. 
 
 
 
 
 
3.4 Discussion 
 Clearly, lysozyme fibril formation shares many similarities with the aggregation 
kinetics and aggregate morphologies of the Alzheimer amyloid peptide Aβ1-40. For 
example, the relative sizes and appearance of lysozyme protofibrils and double-stranded 
fibrils (Fig. 3.4 E) closely match AFM images of comparable Aβ1-40 samples [29]. 
Similarly, the reported growth kinetics of protofibrils are highly reminiscent of kinetic 
data obtained from Aβ1-40 fibrils grown in acidic solutions [31]. These similarities support 
the idea that important aspects of amyloid fibrillogenesis are shared among many 
different types of amyloid proteins, including the formation of oligomeric species, the 
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formation of both oligomers and protofibrils before the emergence of mature fibrils, and 
the shared cross-β-sheet structure of mature fibrils [32]. 
 Aside from these similarities, the data indicate that lysozyme offers distinct 
advantages as a model system for studying critical aspects of amyloid-aggregation 
kinetics. One such advantage is the control over the rate of aggregation via simple 
experimental interventions, such as changes in solution pH or temperature. As a result, 
we were able to retard protofibril nucleation sufficiently to open up an experimental 
window of several hours for studying the intrinsic growth kinetics of oligomer formation, 
unobstructed by interference from other aggregate species (Fig. 3.3 C). Similarly, the 
separation of early stages of oligomer formation from the nucleation and subsequent 
growth of protofibrils permitted us to analyze how oligomer formation is coupled to 
protofibril nucleation and growth. In addition, correlating in situ DLS data with calibrated 
AFM measurements of aggregate dimension during the same experiment qualitatively 
improved the range of conclusions that could be derived from these data sets. 
 
3.4.1 Solution Morphology and Growth Kinetics of Oligomers  
 Before protofibril nucleation, AFM images indicate the presence of oligomeric 
lysozyme aggregates with very narrow size distributions and a volume equivalent to eight 
monomers.  The AFM dimensions of these oligomers (Fig. 3.5 and Table 3.1) are 
consistent with oblate ellipsoids of 3.9 nm height and a 9.5 nm equatorial diameter. The 
hydrodynamic radius for the equivalent sphere of only 3.8 nm naturally accounts for the 
difficulties of separating the small-aggregate peak in DLS into separate monomer and 
oligomer peaks.  Using the a priori knowledge of oligomer geometry enabled us to 
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analyze DLS correlation functions as a simple superposition of only two decay 
components, with decay rates matching those for monomers and oligomers. More 
importantly, the self-consistency between AFM aggregate dimensions and corresponding 
bimodal fits to the DLS data indicated that the oligomer shapes and dimensions derived 
from AFM closely approximated the actual oligomer conformation in solution. The 
correlation functions before protofibril nucleation also indicated that the average 
hydrodynamic radius of a small-aggregate peak increases linearly with incubation period 
(Fig. 3.7 B). Combined with the constant size of oligomers seen in AFM (Fig. 3.4 B), this 
observation implies that oligomer formation initially proceeds at an essentially constant 
rate.  
 
3.4.2 Nucleation and Growth of Protofibrils from Oligomers  
 Aside from opening up a window on the intrinsic growth kinetics of oligomers, 
the DLS data also clearly resolve a prominent nucleation event (Fig. 3.3 C). The 
concurrent emergence of short protofibrils seen in AFM identifies them as the aggregate 
species undergoing nucleation-limited growth. As indicated in Section 3.1, there are 
conflicting results regarding the nucleation and growth process of protofibrils.  The 
correlated DLS and AFM measurements indicate that lysozyme protofibrils both nucleate 
and grow from oligomers. Evidence for this conclusion is provided by both the kinetic 
data on protofibril nucleation from DLS, and by comparisons of protofibril cross sections 
with oligomer dimensions obtained using AFM. First, the presence of a well-defined 
nucleation event (DLS) and the identification of the nucleating species as protofibrils 
(AFM) established that protofibrils undergo nucleation-limited growth. Multiple 
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scenarios have been proposed to explain how protofibril nucleation and growth are linked 
to amyloid monomers and/or oligomers. It has been suggested that protofibrils grow via 
monomer addition, with oligomers only acting as heterogeneous nucleation sites lowering 
the nucleation barrier. The DLS and AFM data on lysozyme indicate, instead, that 
oligomer formation commences without delay upon heating the solutions (Fig. 3.7 B), 
whereas protofibrils nucleation is delayed by several hours. The model of oligomers as 
nucleation sites for protofibril growth by monomers, in contrast, implies that protofibril 
nucleation begins in lock-step with oligomer formation.  
 Alternately, oligomers and protofibrils might both grow directly from monomers, 
but along competing aggregation pathways. In this scenario, oligomers would initially 
grow from monomers. Protofibril formation would be delayed by the need to form a seed. 
After protofibril nucleation, however, they would start to compete with oligomers for the 
same pool of monomeric growth units. The kinetic data per se obtained via DLS cannot 
readily distinguish between the growth of oligomers and protofibrils from monomers 
along competing pathways versus the on-pathway growth of oligomers leading up to the 
nucleation and growth of protofibrils. However, the quantitative agreement between the 
AFM cross sections of protofibrils with the overall dimensions of oligomers (Table 3.1 
and Figs. 3.5 and 3.6) strongly argues in favor of oligomers as the basic nucleation and 
growth unit for protofibrils, and against off-pathway oligomer formation. This further 
implies that oligomer formation represents the rate-limiting step for the nucleation and 
growth of protofibrils.  
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3.4.3 Protofibril Elongation and Self-Assembly into Mature Fibrils 
 Closer inspections of AFM images of short protofibrils, i.e., those observed soon 
after nucleation, suggest how oligomers come together to form protofibrils. Oligomers 
appear to coalesce into linear aggregates along their highly curved perimeters, 
reminiscent of hockey pucks lining up along a surface. This model appears rather distinct 
from predictions of protofibrils with spiral geometries [33] that resemble the helical 
structures observed for mature fibrils with fully developed cross-β-sheet structures [3, 
34]. 
 As the overall contour length of protofibrils increases, their morphology changes 
from short cylindrical rods to curvilinear polymer chains. We presume that this switch in 
protofibril morphology is a direct consequence of the short persistence length for 
protofibril polymers. We cannot rule out, however, that the observed changes in the 
morphology of protofibrils reflect concomitant changes in their internal structure. The 
transition from initially straight to highly curved protofibril geometries can also account 
for the apparent discrepancy between the very modest increase in the hydrodynamic 
radius of protofibrils (Fig. 3.3 C) versus the rather dramatic increase in scattering 
intensity (Fig. 3.3 D) during ~3.5 days of growth. Because the radius of gyration for 
random Gaussian coils grows with the square root of the coil’s contour length, the 
hydrodynamic radius would be expected to increase only slowly with the molecular 
weight of the protofibrils, whereas the scattering intensity would increase with roughly 
the square of the aggregate’s molecular weight. 
 The short persistence length of protofibrils compared with the stiffness of mature 
fibrils (Fig. 3.4 E) further reinforces our assertion that protofibrils do not yet possess the 
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helical cross-β-sheet structure of mature fibrils. Although the increase in diameter of 
mature fibrils over protofibrils should increase their stiffness, the modest 2-fold 
difference in cross section seems insufficient to account for the dramatic increase in 
stiffness from protofibrils to mature fibrils. We presume, instead, that the difference in 
mechanical stiffness arises from the distinct internal organization of protofibrils versus 
mature fibrils. Macromolecular assemblies with a helical organization, such as mature 
amyloid fibrils, tend to be mechanically stiff. The large persistence length of double-
stranded DNA provides a classical example of this behavior. The long, straight shapes of 
double-stranded fibrils match the expected relationship between helical structure and 
mechanical stiffness. Protofibrils, in contrast, seem to lack such mechanical stiffness. 
 
3.4.4 Linear, Hierarchical Assembly Pathway 
 In summary, under acidic growth conditions, lysozyme amyloid growth 
proceeded along a clearly defined and hierarchical aggregation pathway. Amyloid 
monomers aggregated into small oligomers of uniform size, without any apparent 
nucleation barrier. The population of these oligomers increased steadily throughout the 
lag period before protofibril nucleation. After increasing to some critical threshold 
concentration, protofibril nucleation commenced. Protofibrils grew as polymeric 
aggregates of oligomers, with oligomers adding to the ends of existing protofibrils. The 
agreement between the heights and widths of protofibrils and oligomers indicates that 
lysozyme oligomers coalesce along their highly curved perimeter when forming 
protofibrils. It also indicates that protofibrils do not yet share the helically twisted 
structure of mature fibrils [4]. After reaching a contour length of few hundred 
 
 
40 
 
nanometers, protofibrils then appeared to self-assemble into much longer and stiffer 
mature fibrils. 
 Our results regarding correlated AFM and DLS measurements suggest that 
lysozyme amyloid fibril formation at acidic pH values provides a favorable model system 
for detailed analyses of the nucleation and growth kinetics of intermediate amyloid 
aggregates. The well-characterized structure of lysozyme monomers, the ease of 
controlling aggregation kinetics, the clear separation of oligomer formation from 
subsequent growth steps, and the ability to perform in situ characterization of aggregation 
kinetics are advantages that would be difficult to achieve with many other amyloid 
proteins and peptides. Such control provides significant advantages when trying to 
unravel the multifaceted interplay between various intermediate aggregates species, how 
they depend on their internal structure, how they respond to various interventions, and 
how they relate to cellular toxicity. 
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Chapter 4 
Spatial Extent of Charge Repulsion Regulates Assembly Pathways for Lysozyme 
Amyloid Fibrils 
 
4.1 Introduction 
Under the specific conditions used in Chapter 3 we characterized a strict 
hierarchical pathway for lysozyme fibrillogenisis involving an oligomeric intermediate as 
the nucleus and building block for subsequent fibril formation.  At the same time, 
amyloid polymerization can proceed along multiple assembly pathways, not all of which 
give rise to oligomeric intermediates [1,2,3,4]. Fibril assembly of β2-microglobulin, for 
example, can yield "worm-like", "rod-like" or "long straight" intermediates [4]. Different 
aggregation intermediates during amyloid polymerization have been documented, as 
well, for amyloid-β [1,3], human serum albumin [5] or the yeast prion Sup-35 NM [6]. 
Given the significance of oligomeric intermediates to amyloid toxicity, it is important to 
elucidate whether these distinct pathways involve oligomeric intermediates and what 
mechanisms induce the transitions between different assembly pathways. Exposing these 
mechanisms will not only improve our basic understanding of amyloid fibril self 
assembly but could help devise new treatment strategies by directing amyloid formation 
towards less toxic or non-toxic assembly pathways. 
The wide variety of structurally and functionally unrelated proteins that can 
condense into amyloid fibrils with a common β-sheet structure has led to the suggestion 
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that amyloid fibril formation might be driven more by the generic physical chemistry of 
polypeptide chains than the specific biochemical and structural details of amyloid 
proteins [7]. However, it is not clear yet what the relevant biophysical parameters might 
be. Research on phase separation during protein crystallization suggests one such 
possible parameter: the "potential of net force". This ‘‘potential of net force’’ represents 
the average of all (repulsive and attractive) intermolecular interactions among the 
monomers while they are rapidly tumbling in solution. Solution conditions favorable for 
protein crystal growth are characterized by a narrow range of negative values, indicating 
weak net attraction prevailing under these conditions [8,9,10,11,12]. Hence, we wondered 
whether changes in fibril assembly pathways could be correlated to the potential of net 
force. Yet, we are not aware of any systematic efforts at evaluating the prevailing 
intermolecular interactions among amyloidogenic proteins under conditions leading to 
amyloid fibril growth. We were also intrigued by the observation that many in vitro 
assays of fibril formation with native proteins involved highly acidic solution conditions. 
Under these conditions many proteins become highly charged. For example, lysozyme 
monomers carry a positive net charge which can reach +15e at pH = 2.0 [13,14]. Hence, 
we wanted to determine what role nonspecific charge interactions among the partially 
denatured monomers played during the assembly of amyloid fibrils. 
To investigate these questions, we studied in vitro amyloid fibril formation by the 
small enzyme hen egg white lysozyme. There are multiple reasons why lysozyme is a 
favorable system to investigate these correlations. Human mutants of lysozyme are 
among the growing class of natively folded proteins implicated in organ-specific or 
systemic forms of amyloidoses [15,16]. The disease-related lysozyme mutants are 
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structurally nearly identical to their native counterpart while their thermal stability is 
reduced [17]. Finally, amyloid fibrils formed by disease mutants are morphologically as 
well as structurally indistinguishable from those formed by native lysozyme under a wide 
variety of solution conditions [18]. Hence, results obtained with native lysozyme are 
likely to be directly applicable to their disease-related mutants. We investigated lysozyme 
fibril formation at pH= 2.0 and T= 50ºC [19,20,21]. As discussed in Chapter 3, dynamic 
light scattering (DLS) and atomic force microscopy (AFM) can detect and resolve all 
intermediates along different aggregation pathways while assembly proceeds at a 
sufficiently fast rate to perform the numerous experiments required for this study. 
We characterized the nucleation and growth kinetics of lysozyme fibrils under 
conditions of increasing charge screening (increasing salt concentrations) using DLS and 
correlated AFM [20]. Characterizing the morphologies and physical dimensions of 
intermediates emerging during the assembly process permitted us to distinguish among 
different assembly pathways. Using CD spectroscopy we monitored whether changes in 
observed assembly pathways were related to modifications in the residual structure of the 
denatured protein or to shifts in denaturation temperature. The character and strength of 
the net intermolecular interactions among the lysozyme monomers under our growth 
conditions was quantified using static light scattering (SLS).     
 
4.2 Materials and Methods 
Sample preparation and DLS characterization followed the procedures outlined in 
sections 3.2.1 - 3.2.3.  The only noteworthy difference is that solutions were buffered to 
pH = 2 using 25mM KH2PO4.   
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4.2.1 SLS Measurements of Lysozyme’s Net Intermolecular Interactions 
SLS measurements of lysozyme’s interaction parameters were performed under 
two different set of conditions. Below the denaturation temperature of 50 ºC, 
measurements could be completed with NaCl concentrations up to 400 mM without signs 
of aggregate formation (Fig. 4.5A). Conversely, measurements above the denaturing 
temperature (Fig. 4.5C) could only be performed up to NaCl concentrations of 200 mM. 
In the latter case, the presence of a nucleation barrier suppressed the onset of any 
significant aggregation for at least several hours, i.e. long after the completion of our SLS 
measurements. In all cases, reported SLS were derived from averaging 5–10 intensity 
values sampled for 1 minute each. Sequential measurements were scrutinized for any 
signs of systematic, time-dependent increases suggestive of aggregation. Since the SLS 
measurements were performed with the Malvern DLS unit, we simultaneously obtained 
correlation functions. Only samples with polydispersities of their correlation functions 
below 0.07 were included in our measurements.  
Analysis of the SLS data and net protein interactions followed the procedures 
outlined in section 2.4.  The y-axis intercepts for all measurement (see Fig. 4.5A) yielded 
the inverse of lysozyme’s monomeric molecular weight of 14.3 kD. These precautions 
excluded noticeable contamination of the data by the presence of equilibrium or non-
equilibrium aggregation. 
 
4.2.2 Circular Dichroism (CD) 
 CD measurements were carried out on an Aviv Biomedical Circular Dichroism 
Spectrometer, Model 215 with a temperature controlled cell holder. For far-UV 
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wavelength measurements, the protein concentration was 30 µM and the quartz cell path 
length was 1 mm. The wavelength scans were measured from 190– 260 nm with a step 
size of 1 nm and an averaging time of 10 seconds per step. Each measurement was an 
average of three scans with a temperature equilibration time of five minutes. For the 
temperature denaturation scans, the signal was monitored at 222 nm with a temperature 
scan rate of 1ºC per minute. The temperature step size was either 5ºC or 2ºC with a 
temperature equilibration time of 5 minutes and a 10 second averaging time per step. 
 
4.2.3 AFM Characterization of Amyloid Aggregates 
 Most aspects of the AFM characterization were already outlined in sections 3.2.4. 
and 3.2.5.  In short, aliquots of solution were taken from the DLS cuvette during DLS 
measurements for subsequent AFM imaging. Aliquots were diluted 100-fold for 175 mM 
NaCl solutions and 20-fold for 50 mM NaCl solutions. Typically, 75 µL of the solution 
was deposited onto freshly cleaved mica, rinsed with deionized water, and dried with dry 
nitrogen. For 175 mM NaCl solutions, all aggregated samples were deposited onto mica 
for 5 minutes, while monomers were deposited for 15 minutes. For 50 mM NaCl 
solutions, all samples were deposited for 15 minutes except the mature fibrils which were 
deposited for 5 minutes. 
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4.3 Results 
4.3.1 Lysozyme Fibril Growth at Low Salt Concentrations: Self-assembly via 
Monomeric Filaments 
 We determined the nucleation and growth kinetics of lysozyme amyloid fibrils 
grown at different concentrations of sodium chloride by combining DLS with correlated 
AFM [28]. Below approximately 125 mM NaCl, fibril assembly kinetics was 
characterized by extended lag periods lasting multiple days (Fig. 4.1 A, left two panels). 
Throughout the lag period, only particles with physical dimensions and overall volumes 
matching monomeric lysozyme were detected in AFM microscopy (Fig. 4.1 B and C, top 
row and Table 1). During this pre-nucleation period, the shapes of monomers observed 
with AFM imaging became slightly more elongated and flattened, and their apparent 
affinity for the mica surface increased (Fig. 4.1B, top, two left panels). Yet, their overall 
volume clearly identified them as lysozyme monomers (Table 4.1). After multiple days of 
incubation, a nucleation event resulted in the near-simultaneous emergence of not one but 
two aggregate populations with distinctly different hydrodynamic radii. The new 
aggregate peaks were centered at hydrodynamic radii of around 30 and 300 nm, 
respectively (Fig. 4.1 A, second panel). AFM images of aliquots removed during DLS 
measurements indicated that the nucleation event corresponded to the formation of stiff, 
rod-like polymers (Fig. 4.1 B, top row, panel 3&4).  
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Figure 4.1 Monomeric vs. Oligomeric Assembly Pathways for Lysozyme Amyloid Fibrils. (A) In 
situ particle size distributions at different stages of growth and corresponding temporal evolution 
of the detected aggregate peaks during lysozyme fibril growth at 50 mM NaCl (left two panels) 
vs. 175 mM NaCl (right two panels), as obtained from dynamic light scattering measurements. 
The temporal evolution of the aggregate peak radii (1A) highlights the dramatic difference in lag 
periods (see vertical dashed line) and distinctly different nucleation signatures (B) Morphology of 
growth intermediates in the presence of 50 mM NaCl (top row) vs. 175 mM NaCl (bottom row), 
as observed with atomic force microscopy. The vertical dashed line separates samples taken 
before and after the nucleation event detected by DLS. The scale bars represent 50 nm, except for 
the 200 nm scale bars in the last image in either series. (C) Cross sectional areas for the various 
aggregates in (B) measured with calibrated AFM tips. Note the distinctly different cross sections 
for aggregates along the two different assembly pathways. Top: Cross sectional areas of 
monomers, monomeric filaments and mature lysozyme fibrils grown at 50 mM NaCl. At low salt, 
no globular oligomeric species are detected. The cross sections for monomers and monomeric 
filaments are identical then increase by a factor of three for mature fibrils. Bottom: At 
intermediate salt concentrations, ellipsoidal oligomers are formed well before the nucleation 
event seen in DLS. These oligomers have a volume close to eight monomers (see Table 1). The 
filaments emerging after nucleation have a cross section identical to that of the ellipsoidal 
oligomers. Late stage mature fibrils had cross sectional areas close to two oligomeric filaments. 
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Table 4.1 Summary of Aggregate Dimensions for 50mM NaCl vs. 175mM NaCl at pH 2 
 
Monomeric Fibril 
Assembly 
Height 
(nm) 
Width 
(nm) 
Cross-section 
(nm2) 
Volume 
(nm3) 
Monomer (init.) 2.9 ± 0.4 4.8 ± 0.8 / 3.1 ± 0.8 (*) 10.9 ± 2.4 22.6 ± 7.7 
Monomer (pre-nucl.) 2.1 ± 0.4 5.5 ± 0.9 / 4.0 ± 1.0 (*) 9.1 ± 1.8 24.2 ± 8.5 
Monomeric 
Filaments 
2.4 ± 0.4 5.5 ± 0.6 10.4 ± 2.1  
Mature Fibril 5.4 ± 0.3 7.2 ± 0.9 30.5 ± 4.3  
     
Oligomeric Fibril 
Assembly 
Height 
(nm) 
Width 
(nm) 
Cross-section 
(nm2) 
Volume 
(nm3) 
Monomer 3.0 ± 0.2 3.8 ± 0.8 9.0 ± 2.0 22.7 ± 7.0 
Oligomer 3.9 ± 0.1 9.5 ± 1.0 29.1 ± 3.2 184 ± 27.6 
Oligomeric Filament 3.9 ± 0.3 9.5 ± 1.7 29.1 ± 5.5  
Mature Fibril 6.0 ± 0.2 13.9 ± 1.0 65.5 ± 5.2  
(*) || vs   to AFM scan direction 
  
 The two polymeric filament species emerging after nucleation at low-salt 
conditions had cross-sectional areas that were indistinguishable from one another and 
from the monomers present during the latency period (Table 4.1). Therefore, we labeled 
these two populations of nucleating polymers short and long monomeric filaments (MF-S 
and MF-L), respectively. At the late stages of the incubation period, a third population of 
thicker fibers appeared in the AFM images without leaving a distinct signature in the 
DLS signals. The cross-sectional area of these mature fibrils was close to three times that 
of the monomeric filaments (Fig. 4.1 C, top panel). This suggests that mature fibrils were 
assembled via intermolecular crosslinking of three monomeric filaments. Overall, the 
above observations indicate that, at low salt concentrations, amyloid fibril assembly 
involves the near-simultaneous nucleation of two filament populations of different length. 
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Their cross-sections identified them as linear assemblies of monomers. These monomeric 
filaments eventually further cross-assembled into thicker, mature fibrils composed of 
three filaments.  
 We further investigated the near-simultaneous nucleation of two aggregate 
species indicated by DLS. The inversion of DLS correlation functions into aggregate 
peaks can sometimes introduce spurious peaks. However, AFM analysis of the length 
distributions for these polymers also yielded a bimodal peak distribution. For a more 
quantitative comparison of AFM with DLS results we determined the hydrodynamic radii 
corresponding to the near-cylindrical filaments seen in AFM (Fig. 4.1 B) using 
established theoretical predictions [22,23]. Overall, both DLS and AFM do indicate two 
distinct aggregate peaks with comparable ranges of hydrodynamic radii (Fig. 4.2). The 
noticeable difference in the relative peak amplitudes for short vs. long filaments derived 
from DLS vs. AFM is consistent with the increased sensitivity of DLS for larger 
aggregates and differences in surface affinity for short vs. long fibers to the mica surfaces 
used for AFM imaging. Finally, the near-constant values for the hydrodynamic radii vs. 
time for the polymer peaks (Fig. 4.1 A, panel 2) deserve comment. They might result 
from intrinsic slow growth combined with the insensitivity of the hydrodynamic radius to 
increases in cylinder length. We prefer the interpretation, instead, that these intermediates 
exist in a narrow size range, with growth not proceeding via monomer addition but via 
assembly of these preformed ‘‘building blocks’’ into higher-order structures.  
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Figure 4.2 Distribution of Hydrodynamic Radii for Straight Monomeric Filaments: AFM vs. 
DLS. Comparison of the hydrodynamic radii distributions obtained with AFM (shaded bins) vs. 
DLS (solid lines). For ease of comparison, filament lengths measured with AFM were converted 
into their corresponding hydrodynamic radii using established theoretical predictions for straight 
cylinders of variable length [30,31] and diameters close to monomeric filaments (4 nm) or mature 
fibrils (7 nm). 
 
4.3.2 Lysozyme Fibril Growth at Intermediate Salt Concentrations: Self Assembly 
via Oligomeric Intermediates 
 A distinctly different nucleation and growth pattern was observed at salt 
concentrations between 150 mM and 350 mM. Lag periods prior to nucleation were 
shortened from days to a few hours (Fig. 4.1 A, two right panels). DLS measurements 
still yielded a prominent nucleation event, but only a single new aggregate peak emerged. 
The initial hydrodynamic radius of these nuclei was around 20– 30 nm and grew steadily 
to about 50 nm within the following 24 hours. The overall width of the nucleated 
aggregate distribution increased in unison with the hydrodynamic radius. AFM analysis 
of aggregate morphologies in this regime indicated an assembly pathway distinctly 
different from that observed at low salt concentrations (Fig. 4.1 B and C, bottom row). 
Even during the lag period, AFM images revealed the formation of compact oligomeric 
intermediates. These oligomers had the shape of oblate ellipsoids and were characterized 
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by a tight distribution of physical dimensions [20]. Based on the ellipsoidal oligomer 
geometry, the oligomer volume was estimated at eight monomers (Table 1). Following 
nucleation, short polymeric aggregates with a characteristic "beaded" structure emerged 
(Fig. 4.1 B). The cross sections of the beaded polymers matched those of the oligomers 
present prior to nucleation (Table 4.1). We therefore labeled these polymers oligomeric 
filaments (OF). Such beaded structures are similarly referred to as protofibrils [4,24]. As 
growth proceeded, oligomeric filaments assumed an increasingly curvilinear geometry, 
again consistent with observations in several other amyloid systems. Near the end of our 
incubation period, AFM images indicated the formation of larger and much stiffer fibrils. 
No discernable signature of this late stage event was present in the DLS data. The cross 
sections for these late-stage fibrils, obtained from calibrated AFM images, were close to 
twice the cross-sectional area of the oligomeric filaments (Table 4.1). This suggests that 
oligomeric filaments cross-assembled into double-stranded mature fibrils. 
 
4.3.3 Aggregation at High Salt Concentrations: Onset of Disordered Precipitation 
 With NaCl concentration raised beyond 350 mM, the lag period disappeared 
completely and a large aggregate peak emerged immediately (Fig. 4.3 B). The scattering 
intensity associated with these samples increased without any noticeable delay, as well 
(data not shown). The onset of multiple scattering and inner filtering associated with the 
rapid growth of aggregates prevented further quantitative analysis of the DLS data. AFM 
imaging revealed the presence of compact, randomly shaped aggregates of widely 
different sizes (Fig. 4.3 A). A Congo-Red binding assay indicated that these aggregates 
did not contain any fibrillar structures. This is in marked contrast to the noticeable 
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enhancement and red-shift seen with samples grown at lower salt concentrations (Fig. 4.3 
C). Hence, lysozyme aggregation switched from fibril growth with well-defined 
populations of intermediates to a precipitation pathway producing a wide distribution of 
compact precipitates without discernable order or internal structure. 
 
Figure 4.3 Precipitate Formation of Amyloidogenic Lysozyme. (A) AFM image of precipitates 
and their corresponding height distributions observed shortly after the onset of aggregation. (B) 
DLS aggregate peaks of lysozyme in 400 mM NaCl before and right after partial denaturation of 
lysozyme (see vertical dashed line). (C) Congo Red spectra of native lysozyme (—) and 
lysozyme precipitates (&) are indistinguishable. In contrast, mature fibrils grown at lower salt 
concentrations (open circles) induce the red shift and shoulder characteristic for binding to 
amyloid fibrils. 
 
4.3.4 Structure and Thermal Stability of Lysozyme Monomers 
 One possible cause for the observed transition in aggregation behavior between 
low and intermediate salt concentrations could be a salt-induced transition in the structure 
of the lysozyme monomers or a salt-induced shift in the thermal stability of the 
monomers. Studies on human lysozyme indicated that the structure of disease-related 
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mutants was only slightly more disordered than those of native lysozyme. However, the 
stability of the mutants towards thermal denaturation was significantly reduced [16,17]. 
We investigated the structure of lysozyme monomers under our partially denaturing 
solution conditions in the presence of either 50 or 200 mM NaCl. These salt 
concentrations positioned the monomers well inside either the monomeric or oligomeric 
fibril assembly pathways described above. At both salt concentrations lysozyme became 
marginally more disordered when raising the temperature from 37 to 50ºC (data not 
shown). Yet, neither the secondary (see Fig. 4.4 A) nor the tertiary structure (data not 
shown) of lysozyme showed any discernable differences between the two salt 
concentrations. Similarly the midpoint temperature for lysozyme denaturation (55ºC) was 
unaffected by changes in NaCl concentrations (Fig. 4.4B). The steep sigmoidal shape of 
the temperature profile remained invariant with changes in salt concentration, as well. 
Hence, there were no signs that increased NaCl induced additional folding intermediates 
such as a molten globule state [25]. Instead, lysozyme denaturation remained a two-stage 
transition between a native and a denatured state [26]. 
 
Figure 4.4 CD Spectroscopy and Thermal Denaturation of Lysozyme Monomers. (A) Far uv CD 
spectra and (B) normalized thermal denaturation profile of lysozyme measured at 222 nm in 
either 50 mM or 200 mM NaCl. 
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4.3.5 Intermolecular Interactions among Partially Denatured Monomers 
 The above observations imply that there are no pronounced structural changes in 
the secondary or tertiary structure of partially denatured monomers that would account 
for the salt-induced transitions in aggregation behavior. There are several indications 
however that the transition might be related to the effects of salt-screening on the charge 
interactions among the partially denatured lysozyme monomers and the aggregates they 
form. First of all, under the acidic solution conditions used in our experiments lysozyme 
carries a substantial net charge of +15e [13,14]. Furthermore, oligomeric aggregates with 
compact geometries only begin to form as salt concentration increases while the 
monomeric filaments nucleating at low salt concentrations all assume a highly extended 
conformation. The transition from an extended to compact geometry for the initial 
intermediate is consistent with the idea that repulsive charge interactions would suppress 
small compact intermediates until salt screening helps to overcome the energy cost 
imposed by long-range charge repulsion. Finally, it is well established that the 
intermolecular interactions of lysozyme undergo pronounced changes in response to salt-
screening [12,27,28,29].  
 We used static light scattering (SLS) to determine the character of the 
intermolecular interactions among lysozyme monomers undergoing amyloid formation. 
Specifically, we investigated net lysozyme interactions at four different salt 
concentrations (50, 200, 300 and 400 mM NaCl) located in the three different 
aggregation regimes (monomeric vs. oligomeric fibril assembly vs. precipitation), 
respectively. Near the denaturation temperature, solutions at 300 and 400 mM rapidly 
became unstable toward aggregation. Hence, we initially measured interactions at 20ºC. 
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Figure 4.5 A shows the Debye-plot of the scattering parameter KC/R vs. lysozyme 
concentration at each salt concentration. The slope of KC/R for lysozyme is positive at 
low and intermediate salt concentrations and reaches almost zero near 400 mM NaCl. 
Positive slopes at low salt concentrations indicate the prevalence of charge repulsion 
among the monomers. As charge repulsion is increasingly screened out by the double 
layer formed by salt ions, short-range attractive interactions begin to prevail. As shown in 
Fig. 4.5 B, the changes in the intermolecular interaction parameter ks can be readily 
extrapolated and indicate that the sum of short-range attraction and long-range charge 
repulsion begin to cancel each other around 400 mM NaCl. 
 
 
Figure 4.5 Net Interactions among Native and Denatured Lysozyme Monomers. (A) Debye plot 
of the static light scattering intensity (KC/R) vs. lysozyme concentration C at T = 20ºC. The 
positive slope of these curves indicates that the interactions among the lysozyme monomers are 
predominately repulsive. This repulsion becomes screened out once NaCl concentrations reach 
about 400 mM. (B) Plot of the static interaction parameter ks (which is proportional to the slope 
of KCp/R vs. Cp) vs. salt concentration for the Data in A. The dotted line is a guide to the eye 
indicating how repulsion decreases with increasing salt concentration. The two dashed vertical 
lines mark the switch of lysozyme aggregation from monomeric (MF) to oligomeric fibril (OF) 
assembly and, eventually, precipitate formation (P). (C) Change in net interactions as lysozyme 
monomers undergo thermal denaturation in the presence of 50 mM and 200 mM NaCl. The 
vertical dashed line indicates the onset of thermal denaturation at 50uC. Note that, the prevailing 
intermolecular interactions remain repulsive (positive Ks values) even after thermal denaturation. 
At the same time, denaturation at 50 mM NaCl makes lysozyme slightly more repulsive while the 
monomers become less repulsive following denaturation at 200 mM NaCl. 
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 It is not obvious a priori that the intermolecular interactions at 20ºC among folded 
monomers are representative of the interactions among the partially denatured monomers 
near 50ºC. We therefore investigated how temperature-induced denaturation of lysozyme 
altered its intermolecular interactions. These measurements were limited to lower salt 
concentrations where charge repulsion prevented rapid aggregation. In addition, we took 
special precautions to eliminate contamination of interaction measurements from 
aggregate formation (see Section 4.2.1). Intriguingly denaturation in the monomeric vs. 
the oligomeric aggregation regime changed lysozyme’s intermolecular interactions in 
opposite direction (Fig. 4.5 C). In the monomeric aggregation regime ([NaCl] = 50 mM), 
net interactions became slightly more repulsive (slope increases) upon reaching the 
denaturation threshold of 50ºC. This increase is probably indicative of the increased 
volume the monomers take up upon denaturation, which is equivalent to an enhanced 
hard-core repulsion. In contrast, net intermolecular interactions in the oligomeric 
aggregation regime ([NaCl] = 200 mM) became more attractive upon denaturation. 
Hence, at intermediate salt concentrations denatured monomers can sample some of their 
short-range attractive interactions among their exposed hydrophobic cores. Overall, 
though, amyloid fibril formation occurs under conditions in which charge repulsion 
dominates the intermolecular interactions among the denatured monomers. 
 It is important to remember that the net interaction parameter measured here 
quantifies net two-body interactions. Partially denatured monomers will sample a much 
broader range of conformations than their native counterparts. As a result, any specific 
pair of denatured monomers will experience a range of different values for their mutual 
interactions, depending on their respective conformations and the amount of the 
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hydrophobic core these conformations expose. Two-body repulsion further implies that 
that the repulsive contribution from lysozyme’s net charge is unlikely to be overcome by 
only two interacting monomers. Instead, aggregation will require multiple monomers to 
coalesce, thereby increasing their attractive contact regions. This provides a natural 
explanation why at least eight monomers are required to stabilize oligomeric 
intermediates, which is the smallest amyloidogenic intermediate in our system. 
 
4.3.6 Salt-mediated Effects on Amyloid Assembly: Charge-Screening vs. Ion-
Specific Effects on Protein Interactions? 
 The above static scattering data indicate that intermolecular protein interactions 
are strongly modulated by the concentration of sodium chloride. However, there are 
multiple ways salt ions can modulate protein interactions. Besides charge screening via 
the Debye-Huckel double-layer of diffusive ions, ion-specific absorption onto the protein 
or ion-specific changes to solvent-mediated hydrophobic/hydrophilic interactions could 
underlie the interaction changes. Using different salt ions carrying different net charges, 
we evaluated the relative importance of diffusive salt screening vs. ion-specific changes 
to protein interactions. The extent of diffusive charge screening is solely determined by 
the ionic strength I of the solutions, given by 
I = ½ (Za2 Ca + Zc2 Cc) 
where Ca, Cc are the molar concentrations of anions and cations and Za, Zc are their 
respective charge numbers [30]. If salt-mediated charge screening is the dominant 
mechanism for the switch from monomeric to oligomeric fibril assembly, this transition 
should occur at comparable ionic strengths I for different salts. We repeated lysozyme 
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aggregation studies using either NaBr or MgCl2. This selection altered either the co-ion 
(Mg2+ vs. Na+) or counter-ion (Cl- vs. Br-) and included a divalent ion (Mg2+). For both 
salts, though, we observed the same transition from monomeric fibril assembly at low 
ionic strength to oligomeric fibril assembly at intermediate ionic strength (see Fig. 4.6). 
More specifically, the transition occurred near 150 mM for NaCl and NaBr while it 
shifted to between 50 and 75 mM for the divalent Mg2+ ion. Hence, non-specific charge 
screening by salt ions represents the dominant mechanism driving the transition from 
monomeric to oligomeric fibril assembly.  
 
 
Figure 4.6 Lysozyme Fibril Growth in the Presence of MgCl2 vs NaBr. DLS nucleation and 
growth kinetics (left panel) and corresponding AFM images of late-stage aggregates (right panel) 
for lysozyme amyloid fibrils grown in (A) 50 mM MgCl2, (B) 75 mM MgCl2 (C) 100 mM NaBr 
and (D) 150 mM NaBr. 
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4.4 Discussion 
 Together, the above data indicate that aggregation of amyloidogenic lysozyme 
falls into two broad categories: up to modest salt concentrations (<350 mM) lysozyme 
assembles into amyloid fibers while, at elevated salt concentration, disordered protein 
precipitation sets in. Within the regime of moderate salt concentrations, amyloid fibril 
self-assembly itself abruptly switches from a monomeric to an oligomeric assembly 
pathway. Monomeric assembly prevails at low salt concentrations (<150 mM NaCl) and 
involves the nucleation of two filament populations of different length (MF-L and MF-S). 
Their physical characteristics imply that these filaments are linear assemblies of 
monomers. Monomeric filaments eventually cross-link into mature fibrils composed of 
three monomeric filaments (MF) per fibril. No compact, oligomeric intermediates are 
detected in this regime. For intermediate salt concentrations (150 mM≤[NaCl]<350 mM), 
compact oligomeric intermediates are the basic building block for all subsequent fiber 
assemblies. Compact, globular oligomers begin to form without discernable lag period. 
Eventually, oligomeric filaments (OF) nucleate, which themselves grow in length and 
become increasingly curvilinear. As indicated by the doubling in cross-sectional area, 
double-stranded mature fibrils are formed by cross-assembly of two oligomeric filaments 
(OF). 
 The presence of distinct amyloid assembly pathways for lysozyme together with 
the detailed morphological characterization of all intermediates within each pathway, to 
our knowledge, has not been described in this system before. Earlier in vitro studies did 
use pH=2, but typically very low ionic strength. In addition, morphological 
characterizations were performed at the late stages of aggregation, long past the 
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formation of intermediates we report here [19,21,31,32]. Keeping these limitations in 
mind, these earlier reports observed long, very rigid fibrils under low-salt conditions at 
pH=2, consistent with the low-salt monomeric filament pathway in our experiments.  
 The observation of distinct pathways with distinct intermediates, however, does 
resemble those made with β2-microglobulin, the protein underlying dialysis-related 
amyloidosis [4]. Specifically, our monomeric filaments share many features with "long-
straight" fibrils while oligomeric filaments resemble "rod-like" or "worm-like" β2-
microglobulin fibrils. The ability to interconvert rod-like and worm-like β2-
microglobulin fibrils is consistent with the interpretation that the former represent the 
same species of oligomeric filaments at an earlier stage of their growth process. While 
our experiments were not specifically designed to address the question whether 
monomeric and oligomeric assembly pathways compete with one another or represent 
distinct assembly pathways, our data support the latter interpretation. First, mature fibrils 
assembled under either "monomeric" or "oligomeric" growth conditions show clearly 
distinct physical characteristics (Fig. 4.1 C and Table 4.1). Ideally one would like to 
determine the structure of composite fibrils, and the specific number of filaments they 
contain, using high-resolution structural information. Yet, the integer increments in the 
cross-sectional areas of mature fibrils compared to their precursors (Fig. 4.1 C) imply that 
mature fibrils emerge via cross-assembly of either three monomeric filaments 
(monomeric assembly pathway) or two oligomeric filaments (oligomeric assembly 
pathway). Hence, we suppose that monomeric vs. oligomeric growth conditions represent 
two distinct pathways that, under our conditions, do not coexist. 
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4.4.1 Net Protein Interactions as Regulator of Fibril Assembly vs. Precipitation 
 The switch from ordered fibril assembly at low and intermediate salt 
concentrations to disordered precipitation at elevated salt concentrations (Fig. 4.1 vs. 4.3) 
closely correlates with the salt-induced transition from net repulsion to net attraction 
among lysozyme monomers (Fig. 4.5 B). This correlation might appear counterintuitive, 
at first. It is well-established that modest attractive interactions are a necessary 
precondition for protein crystallization of native proteins, while precipitation sets in as 
net attraction exceeds a threshold value [8,11,12,28]. At the same time, the low-salt, low 
pH values used during amyloid fibril growth have been shown to result in net repulsion, 
at least while lysozyme remains below the unfolding transition [12,27,29]. Our data in 
Fig. 4.5 C confirm that net interactions remain repulsive even after lysozyme has 
undergone denaturation. This apparent contradiction can be readily resolved by 
considering the distinctly different role of protein charge interactions during amyloid 
fibril assembly vs. protein crystallization. First, as long as solution temperature was kept 
below the denaturation temperature, lysozyme monomers did indeed never aggregate 
since their mutual interactions are repulsive (Fig. 4.5 C). Raising the solution temperature 
to partially denature lysozyme was a necessary condition for fibril assembly. Such partial 
denaturation as a pre-condition for amyloid formation of native proteins has been well 
documented [33]. However, partial denaturation alone does not turn the prevailing net 
repulsion into attraction (Fig. 4.5 C). Instead, net charge repulsion prevents partially 
denatured monomers from forming intermolecular cross-links, unless their conformations 
permit them to establish beta-sheet bonds (low salt) or micelle-like structures sharing 
hydrophobic interactions. Once net repulsion is abolished, any of the partially denatured 
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monomers can begin associating and random precipitation sets in. Hence, we consider 
charge repulsion to play the role of a ‘‘gate keeper’’ for those conformations of partially 
denatured monomers that can form energetically sufficiently favorable, ordered 
precursors for amyloid formation. 
 
4.4.2 Charge Repulsion as Switch between Monomeric and Oligomeric Assembly 
Pathways 
 So far, we have argued that the transition from net repulsive to attractive protein 
interactions provides a natural explanation for the salt-induced transition from fibril 
assembly to precipitation. We further contend that charge interactions, which remain 
repulsive under fibril growth conditions, also trigger the transition from monomeric to 
oligomeric fibril assembly pathways. We noted that the transition from monomeric to 
oligomeric fibril assembly occurs at comparable ionic strengths, independent of salt 
identity (Fig. 4.6). Debye-Huckel theory indicates that salt screening is associated with an 
intrinsic length scale λD 
λD = INe
Tk
A
Br
2
0
2

 
where ε0 and εr are the vacuum permittivity and dielectric constants of the medium, kBT 
is the thermal energy and I is the ionic strength. λD represents the distance over which salt 
ions screen out the long-range charge repulsion among two charged proteins. To a first 
approximation, it also sets the length scale over which individual charge residues within a 
given protein polymer become screened from one another. Using the ionic strength of 
150 mM for the transition from monomeric to oligomeric assembly and εr = 70 for water 
at T= 50ºC, the corresponding screening length λD becomes 0.78 nm. This is a factor of 
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2–3 below the hydrodynamic radius Rh =1.9 nm for lysozyme [34]. Hence, the transition 
occurs as the repulsive interactions among individual charged residues on the same 
monomer become screened (Fig. 4.7). 
 
 
Figure 4.7 Effects of Salt-mediated Charge Screening on Denatured Monomers. The schematic 
indicates how the spatial extent (Debye screening length λD) of salt-mediated charge screening 
changes the character of the net interactions among denatured monomers and favors the 
formation of different aggregate geometries. The black curvy line represents the protein backbone 
while the blue perimeter symbolizes the short-range attractive protein interactions (hydrophobic, 
dipole-dipole, hydrogen bonding). Individual charged residues are represented by small positive 
spheres, and the extent of charge screening mediated by the salt ions is indicated as a red cloud 
surrounding the charge residues. At low salt concentrations, (monomeric assembly pathway) 
individual charges on the same monomer strongly repel each other and those on neighboring 
monomers. Only those few conformations of denatured monomers that can form intermolecular 
bonds similar to those in the native monomer are aggregation competent. In addition, charge 
repulsion among monomers will favor extended, polymeric structures for intermediates since that 
will separate the monomer charges from each other while preserving sufficient intermolecular 
contacts. When salt screening reduces λD below the separation of charged residues (oligomeric 
assembly pathway) along the monomer backbone, charge repulsion within a given monomer and, 
concurrently, among several aggregated monomers is significantly reduced. This favors the 
formation of more compact (oligomeric) aggregate assemblies and requires fewer monomers to 
share their hydrophobic cores to overcome the residual charge repulsion and loss in 
configurational entropy. Finally, when λD becomes comparable in range to the attractive 
interactions, the charge restrictions on "suitable" aggregate morphologies and favorable monomer 
conformation fall by the wayside and the denatured monomers precipitate randomly out of 
solution. 
 
 
 
67 
 
 This transition from charge repulsion among multiple monomers to partial 
screening of charges within a single monomer puts different constraints on both the 
geometry of intermediate aggregates and their rate of formation. First charge repulsion 
strongly favors only those intermediates that can form sufficiently large numbers of 
favorable intermolecular contacts, similar to those stabilizing the structure of the native 
monomers. At low salt concentrations in particular, the large range of charge repulsion 
favors aggregate structures that are tightly bound while spreading out the charges along 
the aggregate, thereby reducing the repulsive electrostatic contributions to the aggregate’s 
free energy. This charge constraint on aggregate morphology favors linear aggregate 
geometries. As the Debye screening length drops below the typical separation of charged 
groups within a monomer, compact (oligomeric) intermediates become more favorable 
since their geometry provides more opportunities for intermolecular contacts across 
multiple monomeric units. In addition, the entropic constraints are likely to be relaxed 
since a larger number of denatured conformations can participate in sharing their 
hydrophobic cores. Such simultaneous relaxation of both energetic and entropic 
constraints on aggregate geometries provides a compelling reason for the sharp transition 
in aggregation pathways. 
 
4.4.3 Model for the Effects of Charge Interactions on Amyloid Fibril Assembly 
 The above considerations lead us to propose the following model for self-
assembly of lysozyme under amyloidogenic solution conditions (Fig. 4.8). At low salt 
concentrations, only long, extended monomeric filaments can overcome the constraints 
imposed by charge repulsion on bond strength (β-sheets) and aggregate geometry. These 
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monomeric filaments eventually cross-assemble into thicker mature fibrils with three 
filaments linking up to form a fibril strand. As charge repulsion becomes sufficiently 
screened out at intermediate salt concentrations, the formation of compact oligomeric 
intermediates becomes both energetically and entropically more favorable. These 
oligomers form immediately and, as their concentration increases, nucleate and grow into 
oligomeric filaments with a pronounced curvilinear geometry. Oligomeric filaments then 
cross-assemble into mature fibrils composed of two oligomeric filaments per fiber. These 
mature fibrils are clearly distinct from those emerging at low salt concentrations. Finally, 
as screening length decreases further, short-range attractive interactions balance or 
overcome charge repulsion. At that point, constraints on aggregate morphology and 
favorable conformations among the binding partners are eliminated and lysozyme 
monomers assemble into random precipitates. This model provides a compelling 
rationale for the transition among different amyloid assembly pathways and helps to 
rationalize the geometry of their intermediates. It explains why and when partially 
denatured monomers precipitate instead of forming ordered fibril assemblies. Equally 
intriguing, these considerations highlight that charge interactions play distinctly different 
roles during crystallization or liquid-liquid phase separation of native, folded proteins vs. 
their role during self-assembly of fibrillar structure from partially denatured or disordered 
proteins. 
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Figure 4.8 Schematic of Lysozyme Amyloid Assembly as Function of Net Intermolecular 
Interactions. On the left side, the schematic indicates a collection of partially denatured 
monomers in different conformations. The relative distribution of denatured conformations will 
vary both with solution temperature and with the intramolecular interactions, which are affected 
by salt screening, as well. At the lowest salt concentration, charge repulsion suppresses the 
formation of compact oligomeric intermediates with their high local concentration of charge. 
Instead, the monomers have to form extended "short" monomeric filaments that spread out the net 
charge and which are held together by strong hydrogen cross-links (b-sheets). This process has a 
much higher nucleation barrier since many more monomers have to condense into the nucleus 
and the corresponding extended conformations of the denatured monomers are bound to be less 
frequently populated. Short monomeric filaments can assembly head-to-head into long 
monomeric filaments. These, in turn, can form mature fibrils via cross-assembly of three 
monomeric filaments. As salt concentration is increased (middle third of plot), lysozyme 
interactions become less repulsive. In this regime, monomers can assemble into oligomeric 
intermediates if they share their hydrophobic cores. This happens without apparent nucleation 
barrier. The nucleation step here is the formation of oligomeric filaments with, we suppose, 
partially overlapping core structures. These oligomeric filaments can form cross-links and 
restructure to form mature fibrils. At elevated salt concentrations (bottom third of plot), charge 
repulsion among the lysozyme monomers will be screened out and net intermolecular interactions 
become exclusively attractive. In this regime, monomers will undergo diffusion-limited 
aggregation and form random precipitates. 
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Part III: Tau Self-Assembly and Interactions with the 
Chaperone Network 
 
Chapter 5 
Phosphorylation Dynamics Regulate Hsp27 Mediated Tau Aggregation 
 
5.1. Introduction 
 Tau is a protein predominantly expressed in neurons whose main function is to 
stabilize microtubules, the support and transport system for axons.  Filamentous deposits 
of tau have been shown to be either the primary molecular agent or significant 
contributors to multiple senile dementias, such as Pick’s disease and Alzheimer’s disease.  
However, this abnormal aggregation of tau may be offset by the chaperone network’s 
facilitation of degradation and refolding of misfolded tau.  The chaperone network, 
consisting of a large group of proteins, protects the cell by retaining protein quality 
especially in stressful environments when the tendency for protein aggregation is 
increased. As a result, the cellular interactions of chaperone proteins with tau have 
attracted considerable attention [1,2]. One particular small chaperone, called heat shock 
protein 27 or Hsp27 possesses several unique characteristics that set it apart from other 
Hsp’s in its family.  These characteristics include self oligomerization [3], ATP-
independent degradation of its target client [4], and the ability to interact with tau directly 
[5].  Additionally, Hsp27 is among only 4 small Hsp’s expressed in the brain [6] and its 
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over expression is directly related to the accumulation of aberrant proteins in 
neurodegenerative disease [7,8].     
 One of the most well characterized modifications of Hsp27 is its ability to be 
phosphorylated in response to stress at its serine residues 15, 78, and 82 [9].  This 
phosphorylation facilitates the dissociation of dormant oligomeric species into smaller 
active species which may have a significant role in Hsp27 binding and chaperone activity 
[10,11].   To investigate the role of Hsp27 phosphorylation, we characterized tau 
aggregation in vitro in the presence of functionally dynamic wtHsp27 which can cycle 
between phosphorylation and dephosphorylation vs. a static mock-phosphorylated 
version of Hsp27. This complemented research in Dr. Chad Dickey’s lab at USF’s 
College of Molecular Medicine and Pharmacology which assessed Hsp27’s ability to 
promote tau clearance in the brain.  By utilizing both a recombinant wild-type Hsp27 and 
a perpetually pseudo-phosphorylated (3 x S/D) variant generated in Dr. Dickey’s lab, we 
investigated the effects of each variant on the growth of tau fibrils in vitro using dynamic 
light scattering and atomic force microscopy.  These results were then correlated against 
in vivo data.  Towards this end both variants were delivered to transgenic mice using 
extrinsic genetic delivery and the effects on neuronal tau levels in response to the 
presence of either variant was evaluated.  These studies showed the consequences of 
Hsp27 phosphorylation at the molecular and organismal level while further addressing 
the function of dynamic versus static Hsp27.   
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5.2 Materials and Methods 
5.2.1 Recombinant Protein and Purification (Provided by Dr. Dickey’s lab) 
Production and purification of recombinant proteins was based on protocols 
described previously [12]. pET28 vectors carrying His-tagged gene sequences of tau, 
wtHsp27, and 3xS/D Hsp27 (a genetically altered version of Hsp27 that is perpetually 
pseudo-phosphorylated) were transformed into the Escherichia coli strain BL21 (DE3) 
Codon Plus. The latter sequence, 3xS/D Hsp27, consists of the wtHsp27 sequence with 
amino acid substitutions: S15D, S78D, and S82D. Luria broth medium containing 
kanamycin was inoculated with a respective stationary overnight culture. Cultures were 
grown at 30°C to an OD600 of 0.5. Protein expression was induced by addition of 1 mM 
isopropyl-β-D-thiogalactopyranoside for 4 h. Cells were harvested by centrifugation at 
4000 X g for 15 min at 4°C. Pelleted cells were lysed by sonication. All proteins were 
purified via a succession of Ni–NTA–Sepharose chromatography (equilibrated in 50 mM 
NaH2PO4, 500 mM NaCl, 30 mM imidazole, pH 7.5, elution by a step gradient to 300mM 
imidazole). The purity of all proteins was verified on a Coomassie Brilliant Blue-stained 
SDS polyacrylamide gel. 
 
5.2.2 Tau/Hsp27 Assays: Western Blot and Immunoprecipitation (Provided by Dr. 
Dickey’s Lab) 
Western blot (WB) experiments were performed as described previously [13]. 
Samples were mixed with either a 6 X WB sample buffer [50 mM Tris, 10% SDS for 
sucrose cushion (SC) samples] or a 2 Laemmli’s sample buffer [for immunoprecipitation 
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(IP) samples; Bio-Rad], boiled for 10 min, and loaded onto 10% Tris-glycine gels 
(Invitrogen) or 18-well, 10% criterion gels (Bio-Rad). Gel proteins were transferred onto 
nitrocellulose membranes, which were blocked for 60 min at RT in 7% milk. Then, 
membranes were incubated with primary antibodies at a dilution recommended by the 
manufacturer. 
Immunoprecipitation experiments were performed as described previously [13]. 
Purified recombinant tau proteins were incubated and agitated with BSA (as a control), 
wtHsp27, or 3xS/D Hsp27 in protein base buffer (PBB) (57.5 mM Na2HPO4, 334.42 mM 
NaCl, pH 8.0) for 30 min at RT and co-immunoprecipitated with anti-Hsp27 antibody for 
1 h at RT. Protein A slurry (50µl) was added, and the mixture was incubated at RT for 2 
h. Samples were centrifuged, and Protein A beads were precipitated. Pellets were washed 
four times with PBB. The precipitates were subjected to Western blot detection of Hsp27 
and tau using His antibody or tau antibody. 
 
5.2.3 DLS Kinetics during Tau/Hsp27 Aggregation   
To analyze the effects of Hsp27 on in vitro fibril formation by tau, we used 
dynamic light scattering (DLS). Recombinant tau (250 µM) was dialyzed in buffer 
(20mM Tris-HCl, 100mM NaCl, pH 7.4), with Hsp27 at a stoichiometric ratio of 35 parts 
tau to 1 part Hsp27. All proteins were filtered through 0.2 µm syringe filters (Anatop) 
and passed through 100 kDa molecular cutoff filters (Nanosep). Heparin, at one-quarter 
of the molar concentration of tau, was filtered through a 0.2 µm and 0.02 µm syringe 
filter and added to initiate aggregation [14]. Samples were placed in glass cuvettes, and 
aggregation kinetics at 37°C were monitored in 3 min intervals using DLS (Malvern 
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Zetasizer Nano S). The low molar ratios of Hsp27 to tau (typically 1:35) made Hsp27 
contributions to the DLS signal negligible. 
 
5.2.4 AFM Characterization of Tau/Hsp27 Aggregate Morphology 
 At the completion of the DLS measurements, samples were diluted 10 x in buffer, 
and 75µl of the solution were deposited onto freshly cleaved mica for 15 min, rinsed with 
deionized water, and dried with dry nitrogen. Samples were imaged in air with an MFP-
3D atomic-force microscope (Asylum Research) using PPP-FMR (Nanosensor) silicon 
tips with nominal tip radii of 7 nm. The cantilever was driven at 60–70 kHz in alternating 
current mode and a scan rate of 0.5 Hz, acquiring images at 1024x1024 pixel resolution. 
 
5.3 Results  
5.3.1 Wild-type and mock-phosphorylated Hsp27 bind to tau  
 Dr. Dickey’s lab generated two recombinant variants of Hsp27: wild type Hsp27 
(wtHsp27) and a mutant form of Hsp27 where serines 15, 78, and 82 were substituted by 
aspartates (3xS/D Hsp27).  Using immunoprecipitation and western blot they found that 
both variants despite their phosphorylation states were able to bind to tau as shown in 
Fig. 5.1. 
 
 
 
 
 
 
 
Figure 5.1 Both wtHsp27 and 3xS/D Hsp27 bind tau.  CoIP-WB of His-tagged recombinant tau 
(rTau) with rabbit anti-tau antibody showed that rTau coprecipitated with both wt and 3xS/D 
Hsp27 but not BSA.   
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5.3.2 Wild-type and Mock-phosphorylated Hsp27 Abrogate the Aggregation of Tau 
in-vitro   
To characterize the effects of Hsp27 on in vitro tau fibril growth, we used 
recombinantly expressed human 4R0N tau, wild-type Hsp27 and a mock-phosphorylated 
mutant 3xS/D provided by Dr. Dickey’s lab.  We first determined the sizes for tau and 
Hsp27 using dynamic light scattering after filtration through 0.2 µm syringe filters and 
100 kDa molecular weight cutoff filters.  It should be noted that filtration was necessary 
for DLS measurements despite the protein purity confirmed with SDS gel 
chromatography.  The initial hydrodynamic radius of tau was approximately 6 nm, 
matching well with predictions of 4.9 - 6.4 nm for a disordered protein with 383 amino 
acids [15].  Native Hsp27 displayed both a monomer peak around 4.7 nm and a small 
aggregate peak consistent with the self-oligomerization of Hsp27.   
 
Figure 5.2 Dynamic Light Scattering of Heparin-Induced Tau Fibril Formation Inhibited by 
wtHsp27 and 3xS/D Hsp27 (A) Tau mean aggregate radius monitored for 5 days in the absence 
(■) or presence of either wtHsp27 (○) or 3xS/D Hsp27 (□) at a molar ratio of 35 moles of tau to 1 
mole of Hsp27. (B and C) Particle size distribution of tau alone (■) or in combination with 
wtHsp27 (○) or 3xS/D Hsp27 (□) at day 0 (B) and day 5 (C). 
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 In order to initiate and accelerate the growth of tau fibrils in vitro we added 
heparin, a small (~3kDa) highly negatively charged polysaccharide, at a ratio of 4 tau 
molecules per 1 heparin molecule.  Immediately after adding heparin, we saw an increase 
in the hydrodynamic radius from approximately 6 nm to 8 nm (Fig. 5.2 B).  This could be 
due to changes in the viscosity by adding heparin, changes to the net interactions of tau 
molecules, or instantaneous aggregation.  We then monitored changes to the 
hydrodynamic radius of tau at 37 °C using dynamic light scattering for 5 days.   We saw 
a steady increase in the average hydrodynamic radius (Fig. 5.2 A) and after 5 days a large 
population of ~30-40 nm particles was present (Fig. 5.2 C).  AFM microscopy confirmed 
the formation of short, straight fibrils (Fig. 5.3 B) after 5 days of incubation.   
 
Figure 5.3 Atomic Force Microscopy of Tau Aggregation in the presence of Hsp27’s.  (A) AFM 
image of tau monomers before addition of heparin or incubation at 37°C (B) AFM image of tau 
aggregation and the existence of fibrils after 5 days of incubation at 37°C in the presence of 
heparin at a molar ratio of 4 tau : 1 heparin.  (C) AFM image of tau in the presence of wtHsp27 
after 5 days of incubation under the same conditions as B (D) AFM image of tau in the presence 
of 3xS/D Hsp27 after 5 days of incubation under the same conditions as B.  
  
 We then characterized the aggregation kinetics of tau in the presence of wtHsp27.  
In order to monitor changes to the hydrodynamic radius of tau using DLS, we needed to 
work with low stoichiometric ratios of wtHsp27 and confirm that the contributions of 
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wtHsp27 to the overall correlation function were negligible.   We used a ratio of 35:1 for 
tau to wtHsp27 respectively and confirmed that the initial radius was approximately 6 nm 
and immediately after adding heparin increased to 8 nm, comparable to our results 
without wtHsp27 (Fig. 5.2 B).  We monitored the co-incubation of tau and wtHsp27 for 5 
days.  The wtHsp27 significantly reduced the increases in hydrodynamic radius with time 
as compared to the control experiment of tau without wtHsp27 (Fig. 5.2 A).  
Additionally, after 5 days in the presence of wtHsp27 there was a lack of any discernable 
separate aggregate peak as shown in the control experiment (Fig. 5.2 C).  AFM 
microscopy confirmed that wtHsp27 completely abolished the formation of large straight 
fibrils (Fig. 5.3 C).   
In order to determine the effects of phosphorylation on Hsp27 activity, we used 
the mock-phosphorylated mutant 3xS/D of Hsp27 (serines 15, 78, and 82 were 
substituted by aspartates) and co-incubated it with tau at the same 35:1 ratio as before.    
Although, there was less aggregation as compared to tau alone, the 3xS/D Hsp27 was less 
effective compared to wtHsp27 at inhibiting increases in hydrodynamic radius (Fig. 5.2  
A) and was unable to eliminate the discernable aggregate peak (Fig. 5.2 C).  Using AFM 
microscopy we confirmed that this aggregate peak did not arise from the formation of 
straight fibrils but from larger compact aggregates (Fig. 5.3 D). 
 
5.3.3 Tau Clearance by Hsp27 in-vivo is Dependent on Phosphorylation Dynamics 
 In vivo experiments performed in Dr. Dickey’s lab used the rTg4510 transgenic 
mouse model to test the effects of both Hsp27 variants on tau pathology in neurons by 
bilaterally injecting their hippocampi with AAV9-expressing wtHsp27, 3xS/D Hsp27, or 
GFP (Fig. 5.4). Because it had already been demonstrated that these mice begin to 
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develop tangle pathology as early as 3 months of age [13] and that all neurons were not 
transduced by AAV, these studies were initiated in 4-month-old mice.  Tissues were 
harvested 2 months later to ensure that most hippocampal neurons would have tau 
accumulation [13]. This design allowed Dr. Dickey’s lab to assess the tau burden in 
neurons that were successfully transduced with viral particles encoding each Hsp27 
variant or GFP by triple labeling tissue sections with antibodies specific for NeuN (blue), 
Hsp27 (green), and tau (red) (Fig. 5.4).   
 
Figure 5.4 Neuronal overexpression of Hsp27–AAV9 variants differentially modulates neuronal 
tau levels. Confocal images of immunofluorescently labeled neurons (blue), tau (red), and Hsp27 
or GFP (green) in CA1 from rTg4510 mice injected with AAV9-expressing wtHsp27, 3xS/D 
Hsp27, or GFP (scale bar, 50nm).  Quantification of red signal (tau) in blue areas (neurons) 
sharing positive green signal (Hsp27 or GFP).  
 
 Interestingly, the results indicated very few wtHsp27-expressing neurons that also 
contained tau aggregates, suggesting that wtHsp27 facilitated tau clearance (Fig. 5.4). 
This was in stark contrast to neurons positively stained for Hsp27 from mice receiving 
the 3xS/D Hsp27 variant. In these mice, tau levels were actually higher relative to mice 
injected with GFP–AAV. Quantification of tau (red signal) in neurons (blue areas) 
sharing positive green signal [Hsp27 or GFP] showed that, compared with GFP-
 
 
82 
 
expressing neurons (n = 264), tau signal was reduced by 66 ± 8% (n = 296) and increased 
by 50 ± 11% in neurons expressing wtHsp27 and 3xS/D Hsp27 (n = 302), respectively 
(Fig. 5.4). wtHsp27 was able to reduce tau levels in neurons; however, it was unclear 
whether it was preventing tau aggregation or actively disrupting preformed tau structures.  
 
 
5.3.4 Hsp27 is Unable to Disrupt Preformed Tau Aggregates 
We used DLS to specifically address whether Hsp27 could actively disrupt 
preformed tau structures. Recombinant tau was incubated with heparin for 22 days before 
the addition of recombinant wtHsp27 at the same molar ratio of 35 tau : 1 Hsp27. Wild-
type Hsp27 was unable to disrupt preformed aggregates (Fig. 5.5), suggesting that, for 
Hsp27 to impact neuronal function, it should be administered at a time before robust tau 
aggregation.   
 
 
Figure 5.5 wtHsp27 is unable to disrupt pre-formed tau aggregates. Mean hydrodynamic radius 
measured by DLS of heparin-induced tau fibrils before and after the addition of wtHsp27 at a 
ratio of 35 tau : 1 Hsp27.  Tau fibrils were grown for 22 days and confirmed to have reached a 
steady state by the fixed hydrodynamic radius in DLS.  The addition of wtHsp27 was unable to 
alter the size of these aggregates even after an additional day of incubation. 
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5.4 Discussion 
 Using a combination of biophysical and physiological approaches, we have 
discovered an important aspect of Hsp27 biology that, to this point, was unknown. 
Although both mock-phosphorylated Hsp27 and wild-type Hsp27 could bind and prevent 
tau aggregation in vitro, only wild-type Hsp27 was able to clear tau from the brain.  
Because the mock-phosphorylated form of Hsp27 actually stabilized tau in the brain, it 
suggests that Hsp27 must be able to cycle between phosphorylated and 
nonphosphorylated states for it to succeed at clearing abnormal clients such as tau. 
Otherwise, Hsp27 might actually facilitate accumulation of soluble tau intermediates. 
 Although, both phosphorylated and nonphosphorylated Hsp27 can bind to tau in 
Alzheimer’s brain [5], preventing Hsp27 dephosphorylation might thwart its capacity to 
clear bound clients, preserving them as aberrant intermediates. Thus, Hsp27 may be a 
double-edged sword depending on the context of the neuron: Hsp27 may be highly 
effective at preventing aggregation of unfolded proteins resulting from acute stress events 
in neurons. The bound client would be preserved for recycling and functional restoration, 
the most energetically favorable outcome for proteostasis in otherwise healthy neurons.  
However, chronic stress would likely also cause chronic protein instability in neurons. In 
this scenario, functional recycling of unfolded or aberrant proteins may not be feasible in 
neurons that are already operating at suboptimal levels. Simply sequestering these clients 
into ordered aggregates would become the best option for survival, albeit at a reduced 
capacity [16, 17, 18, 19, 20, 21].  
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 Our findings also show that the oligomerization state of Hsp27 is not critically 
linked to its ability to prevent tau aggregation; only its ability to promote tau clearance in 
vivo. Perhaps discrete multimeric Hsp27 species can prevent tau aggregation via distinct 
physical interactions, but the ultimate outcome in the cell is the same. Thus, these unique 
Hsp27 multimers may represent different structural entities despite their primary 
composition. Each of these entities could have their own function and targets.  
 In summary, therapeutic approaches to modify Hsp27 levels and function may be 
effective strategies for treating distinct neurological disorders. However, the contextual 
environment of the neuron must be considered to select the most appropriate strategy for 
each disease. In some circumstances, increasing or decreasing Hsp27 levels may be 
beneficial, but in others it might be more appropriate to regulate the phosphorylation state 
and thus the oligomerization properties of Hsp27. By defining these important 
mechanisms, we can move toward more individualized and effective therapeutic 
strategies targeting the chaperone network. 
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Chapter 6 
FKBP51 and Hsp90 as Modulators of Tau Aggregation 
 
6.1 Introduction 
 As discussed in Chapter 5, the chaperone network’s primary goal is to maintain 
protein homeostasis by directing the cellular traffic, refolding, and degradation of 
abnormal proteins.  As a result, it has received increasing attention as a therapeutic target 
for decreasing abnormal levels of tau in neurodegenerative diseases [1].     However, 
chaperones typically induce degradation only as a last resort and often will, instead, try to 
refold or re-activate their clients to return them at least in a partially activated state [2]. 
For example, in Chapter 5 we established that mock-phosphorylated Hsp27 inhibited tau 
fibrillar aggregation in vitro, while enhancing the accumulation of soluble tau 
intermediates in vivo.  Here we further extend our studies to investigate the role of Hsp90 
and its binding partners on tau aggregation in vitro.   
 Frequently, hsp’s form large chaperone complexes with co-chaperones organized 
by the central player Hsp90.  Hsp90, one of the most abundant cytosolic proteins, 
accounts for 1% of all proteins even in the absence of stress and its expression is 
increased 10 fold in response to stress [3].  Hsp90 consists of two isoforms, Hsp90α and 
Hsp90β.  These isoforms are almost 85% homologous.  However Hsp90α exists 
predominantly as a homodimer while Hsp90β exists as a monomer [4].  The tendency of 
Hsp90α to form dimers can be mapped to two amino acid differences in the C terminal 
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domain affecting the conformational flexibility and affinity for different binding partners 
[5,6].  Previous studies have shown that Hsp90α not only binds to tau but can induce a 
conformational switch which enhances tau phosphorylation in vitro [7].  In vivo, EC102, 
a drug which inhibits Hsp90 activity, decreased levels of phosphorylated tau in both 
HeLa cells and brains of transgenic mice leaving normal tau levels unaffected [8].    
 The most important regulators of the Hsp90 machinery are the co-chaperones 
which include protein kinases, transcription factors, and Tetratricopeptide (TPR) binding 
domain proteins [1].  One specific class of co-chaperones called immunophilins possesses 
peptidylprolyl cis/trans isomerase activity (PPIase) i.e. the ability to catalyze the cis to 
trans conformation of the proline-peptide backbone of a protein [9].  This PPIase activity 
is often the rate limiting step in protein folding and can affect tau function, 
phosphorylation, and ubiquitinylation (ubiquitin-mediated protein degradation).  Recent 
studies have revealed that two large immunophilins, FKBP51 and FKBP52, are not only 
highly expressed in neurons but can directly interact with tau regardless of Hsp90 activity 
[10,11,12].  It has even been shown that over expression of FKBP51 in HeLa cells can 
enhance levels of both phosphorylated and total tau by 80% [12].   
 To better understand the effects of Hsp90α, Hsp90β, and FKBP51 on tau 
aggregation, we used dynamic light scattering and atomic force microscopy to compare 
the effectiveness of each chaperone on modulating tau aggregation and morphology in 
vitro.  By altering the pH of the solution, we compared the effects of each chaperone on 
tau fibrillar vs. tau oligomeric growth conditions and modeled known chaperone 
complexes by using combinations of FKBP51 and Hsp90 in order to suggest which 
chaperone may play the dominant role during tau binding.   
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6.2 Materials and Methods  
6.2.1 Recombinant Protein and Purification (Provided by Dr. Chad Dickey’s Lab) 
For details regarding the expression and purifications, see Section 5.2.1.  For in 
vitro experiments, all proteins were dialyzed overnight into 20mM Tris-HCl, 100mM 
NaCl buffer at the appropriate pH.  The concentrations of purified tau, FKBP51, 
FKBP51M (F130A), Hsp90α, and Hsp90β were determined using the uv extinction 
coefficients of 280 0.753, 0.754, 0.617, and 0.603 ml mg-1 cm-1 calculated according to 
Gill and von Hippel (1989) [13]. 
 
6.2.2 DLS Kinetics during Tau/Hsp90/FKBP51 Fibril vs. Oligomer Kinetics  
 We used dynamic light scattering (DLS) to quantify the effects of FKBP and 
Hsp90 on in vitro fibril formation of tau.   Recombinant tau (300 μM) was suspended in 
buffer (20mM Tris-HCl, 100mM NaCl, pH 7.4) with FKBP's and/or Hsp90's at a 
stoichiometric ratio of 50 parts tau to 1 part FKBP and/or 1 part Hsp90. All proteins were 
filtered through 0.2 μm syringe filters (Anotop) and passed through 100 kDa molecular 
cutoff filters (Nanosep). Hsp90 and FKBP required an additional filtration through a 0.02 
μm filter (Anotop).  Heparin, filtered through 0.2 μm and 0.02 μm syringe filter, was 
added at one-quarter of the molar concentration of tau to initiate aggregation. 
 Samples were placed in a Greiner Bio-One 384 well glass-bottom plate (781892), 
incubated at 37°C and aggregation kinetics in each well were monitored for 3 min every 
2-3 hours using a Wyatt DynaPro DLS Plate Reader Plus. The low molar ratios of FKBP 
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or Hsp90 to tau (typically 1:50) insured that the DLS correlation function was dominated 
by scattering of tau. 
 To analyze the effects of FKBP and Hsp90 on in vitro oligomer formation of tau, 
all protocols remained the same except the buffer pH was 8.3.  In addition to using 
heparin, we alternatively used arachidonic acid, filtered through a 0.02 μm syringe filter 
and added at one-quarter of the molar concentration of tau, to initiate oligomer formation 
at pH 8.3. 
 
6.2.3 AFM Characterization of Tau/Hsp90/FKBP51 Aggregates 
 For details about the AFM measurement protocol, see Section 5.2.4 
 
 
6.3 Results  
6.3.1 Hsp90α and Hsp90β: Opposing Effects on Tau Fibril Formation  
 To characterize the effects of Hsp90 on in vitro tau fibril growth, we used 
recombinantly expressed human 4R0N tau, Hsp90α, and Hsp90β provided by Dr. Chad 
Dickey’s lab.  In order to initiate and accelerate the growth of tau fibrils in vitro we added 
heparin, a small (~3kDa) highly negatively charged polysaccharide, at a ratio of 4 tau 
molecules per 1 heparin molecule in 100mM NaCl, 20mM Tris-HCl pH 7.4 buffer.  We 
monitored changes to the hydrodynamic radius of tau at 37 °C using a Wyatt DynaPro 
DLS Plate Reader Plus.   This allowed us to monitor identical controls in a well plate 
from the same protein batch eliminating possible differences in cluster contamination 
which can significantly alter aggregation kinetics.  We found a sigmoidal increase in the 
hydrodynamic radius for tau alone and after 6 days saw an increase in radius from 5 nm 
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to 47 nm (Fig. 6.1).  AFM microscopy after 6 days incubation confirmed the formation of 
straight fibrils a few hundred nanometers in length (Fig. 6.2).   
 
Figure 6.1 Dynamic Light Scattering of Heparin-Induced Tau Fibril Growth at pH 7.4 
Accelerated by Hsp90α and inhibited by Hsp90β.  Tau mean radius monitored for 6 days in the 
absence (■) or presence of either Hsp90α (■) or Hsp90β (■) at a molar ratio of 50 moles of tau to 
1 mole of Hsp90. 
 
 We then characterized the aggregation kinetics of tau in the presence of Hsp90α 
or Hsp90β.  In order to monitor changes to the hydrodynamic radius of tau using DLS, 
we needed to work with low stoichiometric ratios of Hsp90 and confirm that the 
contributions of Hsp90 to the overall correlation function were negligible.   We used a 
50:1 ratio of tau to Hsp90, respectively, and confirmed that the initial radius for tau in the 
presence of Hsp90 was approximately 5 nm, comparable to our results for tau in the 
absence of Hsp90.  We then co-incubated tau with Hsp90α or Hsp90β for 6 days.  The 
presence of Hsp90α significantly enhanced the increases in hydrodynamic radius with 
time, reaching a hydrodynamic radius of Rh ≈ 60 nm after 6 days as compared to the 
control experiment of tau without Hsp90α (Fig. 6.1).  AFM microscopy confirmed that 
Hsp90α significantly promoted the formation of longer straighter fibrils and inhibited the 
formation of large oligomers (Fig. 6.2 B).  These results were supported by the enhanced 
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fluorescence responses of thioflavin, a selective amyloid indicator dye, for incubation of 
tau in the presence vs. absence of Hsp90α (Fig 6.3).    
 Contrary to Hsp90α, the presence of Hsp90β resulted in smaller and slower 
increases in hydrodynamic radius with time reaching a maximal Rh of approx. 40 nm 
after 6 days (Fig. 6.1).  As shown in Figure 6.2, AFM microscopy confirmed that Hsp90β 
significantly reduced the typical length of tau fibrils and possibly even the overall 
number of tau fibrils.  Again, these observations were corroborated by decreased levels of 
thioflavin T fluorescence response for tau fibrils in the presence of Hsp90β compared to 
tau alone (Fig. 6.3).    
 
Figure 6.2 Atomic Force Microscopy of Tau Fibrillar Aggregation at pH 7.4 in the presence of 
Hsp90’s.  (A) AFM image of tau aggregation and the existence of fibrils after 6 days of 
incubation at 37°C in the presence of heparin at a molar ratio of 4 tau : 1 heparin.  (B) AFM 
image of tau in the presence of Hsp90α after 6 days of incubation under the same conditions as B 
(C) AFM image of tau in the presence of Hsp90β after 6 days of incubation under the same 
conditions as B.  All images are 2μm x 2μm.  
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Figure 6.3 Thioflavin Fluorescence of Heparin-Induced Tau Fibril Growth at pH 7.4 accelerated 
by Hsp90α and inhibited by Hsp90β.  After incubation at 37 ºC for 6 days, Thioflavin T (ThT) 
fluorescence was measured by removing a small aliquot of the sample and diluting 30 fold into 
10μm ThT/buffer.  The maximum fluorescence intensity was measured at 485 nm.  The tau 
control in the absence of Hsp90 was normalized to 100%.  Data is an average of 3 dilutions for 
each sample from the DLS experiment in Figure 6.1. 
 
6.3.2 FKBP51M (F130A) but not FKBP51wt Retards Tau Fibril Formation  
 Previous in vitro studies suggested that the Hsp90 co-chaperone FKBP51wt can 
prevent thermal protein aggregation of citrate synthase even without Hsp90 [9].  Hence, 
we were interested in the effects of FKBP51 on tau aggregation in vitro.  We used 
recombinantly expressed human 4R0N tau, FKBP51wt, and a PPIase-deficient mutant 
form of FKBP51 (F130A), provided by Dr. Chad Dickey’s lab, which was determined to 
have <1% isomerase activity [12].   Under the fibril growth conditions established in 
section 6.3.2, we again monitored changes in the hydrodynamic radius of tau in the 
presence or absence of FKBP51wt or FKBP51 mutant (F130A).  The presence of 
FKBP51wt had no effect on tau aggregation kinetics (Fig. 6.4) and AFM showed tau 
fibrils of similar lengths in the presence or absence of FKBP51wt (Fig. 6.5). 
 In contrast to FKBP51wt, the mutant form F130A decreased the mean radius 
measured by DLS from Rh ≈ 47 nm for the tau control to Rh ≈ 33 nm for tau in the 
presence of F130A (Fig 6.4).  As shown in Figure 6.5, AFM microscopy confirmed the 
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decrease in the number and length of tau fibrils in the presence of F130A.  These results 
matched the decreased Thioflavin T fluorescence response for tau in the presence of 
F130A as compared to tau along or the presence of FKBP51wt (Fig. 6.6). 
 
Figure 6.4 Dynamic Light Scattering of Heparin-Induced Tau Fibril Growth at pH 7.4 Inhibited 
by FKBP51M (F130A) but unchanged by FKBP51wt.  Tau mean radius monitored for 6 days in 
the absence (■) or presence of either FKBP51wt (■) or FKBP51M (F130A) (■) at a molar ratio of 
50 moles of tau to 1 mole of FKBP51. 
 
 
Figure 6.5 Atomic Force Microscopy of Heparin-Induced Tau Fibrillar Aggregation at pH 7.4 in 
the presence of FKBP’s. (A) AFM image of tau aggregation and the existence of fibrils after 6 
days of incubation at 37°C in the presence of heparin at a molar ratio of 4 tau : 1 heparin.  (B) 
AFM image of tau in the presence of FKBP51wt after 6 days of incubation under the same 
conditions as B. (C) AFM image of tau in the presence of FKBP51M (F130A) after 6 days of 
incubation under the same conditions as B.  All images are 1μm x 1μm. 
 
 
 
95 
 
. 
Figure 6.6 Thioflavin Fluorescence of Heparin-Induced Tau Fibril Growth at pH 7.4 unchanged 
by the presence of FKBP51wt and inhibited by FKBP51M (F130A).  After incubation at 37 ºC for 
6 days, Thioflavin T fluorescence was measured by removing a small aliquot of the sample and 
diluting 30 fold into 10μm ThT/buffer.  The maximum fluorescence intensity was measured at 
485 nm.  The tau control in the absence of FKBP51 was normalized to 100%.  Data is an average 
of 3 dilutions for each sample from the DLS experiments in Figures 6.4 and 6.5. 
 
 
6.3.3 FKBP51wt and FKBP51M (F130A) modulations are unaffected by the 
presence of Hsp90β while occasionally affected by Hsp90α during fibril growth  
 In contrast to the individual effects of Hsp90’s and FKBP51’s effect on in vitro 
tau aggregation, we focused the above in vitro studies on how chaperones interact with 
their target substrate in vivo once they form a complex.  We therefore investigated the 
role of different combinations of Hsp90 and FKBP51 to determine if immunophilins such 
as FKBP51 could interact with tau directly through the Hsp90 chaperone complex.  We 
used the same fibril growth conditions as Sections 6.3.2 and 6.3.3 and found that the 
aggregation kinetics for tau in the presence of FKBP51wt was unaffected by the 
additional presence of Hsp90β and slightly enhanced by the presence of Hsp90α (Fig 
6.7).  As shown in Figure 6.8, neither the additional presence of Hsp90α or Hsp90β 
affected the aggregation kinetics of tau and FKBP51M (F130A). 
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Figure 6.7 Dynamic Light Scattering of Heparin-Induced Tau Fibril Growth at pH 7.4 in the 
presence of different combinations of FKBP51wt, Hsp90α, and Hsp90β.  (A) Tau mean radius 
monitored for 6 days in the absence (■) or presence of either 51wt (■), Hsp90α (■), or both 51wt 
and Hsp90α (■) at a molar ratio of 50 moles of tau to 1 mole of FKBP51wt and/or Hsp90α.  (B) 
Tau mean radius monitored for 6 days in the absence (■) or presence of either 51wt (■), Hsp90β 
(■), or both 51wt and Hsp90β (■) at a molar ratio of 50 moles of tau to 1 mole of FKBP51wt 
and/or Hsp90β.   
 
 
Figure 6.8 Dynamic Light Scattering of Heparin-Induced Tau Fibril Growth at pH 7.4 in the 
presence of different combinations of FKBP51M (F130A), Hsp90α, and Hsp90β.  (A) Tau mean 
radius monitored for 6 days in the absence (■) or presence of either F130A (■), Hsp90α (■), or 
both F130A and Hsp90α (■) at a molar ratio of 50 moles of tau to 1 mole of F130A and/or 
Hsp90α.  (B)  Tau mean radius monitored for 6 days in the absence (■) or presence of either 
F130A (■), Hsp90β (■), or both F130A and Hsp90β (■) at a molar ratio of 50 moles of tau to 1 
mole of F130A and/or Hsp90β.   
 
A B
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6.3.4 Hsp90α and Hsp90β Reduce Hydrodynamic Size of Tau Oligomers  
 Recent studies have indicated that tangle formation or the growth of tau fibrils is 
actually the “off-track” pathway and may not lead to neuronal death.  Instead it is 
suggested that the oligomers and tau fragments are the more toxic tau species in vivo. 
[1,14,15,16].  Therefore by increasing the pH to 8.3 and leaving all other conditions the 
same, we investigated a system of tau aggregation dominated by oligomer growth rather 
than fibril formation.     
 
Figure 6.9 Dynamic Light Scattering of Heparin-Induced Tau Oligomer Growth at pH 8.3 
inhibited by the presence of Hsp90α and Hsp90β.  Tau mean radius monitored for 8 days in the 
absence (■) or presence of either Hsp90α (■), Hsp90β (■), or both Hsp90α and Hsp90β (■) at a 
molar ratio of 50 moles of tau to 1 mole of Hsp90α and/or Hsp90β.   
 
 Rather than the sigmoidal growth kinetics seen for fibril growth conditions at pH 
7.4, tau aggregation at pH 8.3 caused the average hydrodynamic radius of tau to increase 
without delay and without reaching a plateau (Fig. 6.9).  As shown in Figure 6.10, AFM 
microscopy confirmed the presence of oligomeric aggregates with heights ranging from 6 
to 10 nm comparable to the fibril heights of 6 to 7 nm seen at pH 7.4.  Given the narrow 
distribution of aggregate heights seen with AFM and the steady increase in hydrodynamic 
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radius observed by DLS, these results imply that tau aggregation at pH 8.3 did not 
resemble amorphous precipitation.     
 
Figure 6.10 Atomic Force Microscopy of Heparin-Induced Tau Oligomer Aggregation at pH 8.3 
in the presence of Hsp90’s. (A) AFM image of tau monomers before addition of heparin or 
incubation at 37°C. (B) AFM image of tau aggregation and the existence of oligomeric 
aggregates after 8 days of incubation at 37°C in the presence of heparin at a molar ratio of 4 tau : 
1 heparin.  (C) AFM image of tau in the presence of Hsp90α after 8 days of incubation under the 
same conditions as B. (D) AFM image of tau in the presence of Hsp90β after 8 days of incubation 
under the same conditions as B.  All images are 2μm x 2μm. 
 
 
 We further characterized the oligomeric growth of tau in the presence of Hsp90α, 
Hsp90β, or both using a molar ratio of 50:1 for tau to Hsp90’s respectively.  The presence 
of Hsp90α and/or Hsp90β inhibited the rate of the hydrodynamic radius increase with 
time, although with different efficacies.  After 8 days, tau alone reached a hydrodynamic 
radius of Rh ≈ 35.3 nm while tau in the presence of Hsp90α reached Rh ≈ 27.7 nm, tau in 
the presence of Hsp90β reached Rh ≈ 32.5 nm, and tau in the presence of both Hsp90α 
and Hsp90β reached Rh ≈ 29.7 nm (Fig. 6.9).  AFM microscopy confirmed that the 
 
 
99 
 
number of larger tau oligomers was greatly reduced in the presence of Hsp90α (typical 
heights 6 nm or less compared to the larger 10 nm heights for the tau control; see (Fig 
6.10)). At the same time, even though the average hydrodynamic size of tau aggregates 
decreased, aggregation had increased the number of smaller oligomeric aggregates.   
 We further extended this study, by using arachidonic acid, a negatively charged 
fatty acid at neutral pH and another commonly used inducer for tau aggregation.  At a 
molar ratio of 4 tau molecules per 1 arachidonic acid molecule in 100mM NaCl, 20mM 
Tris-HCl pH 8.3 buffer, we monitored changes to the average hydrodynamic radius of tau 
at 37 °C using a Wyatt DLS plate reader.  The DLS kinetics showed a steady increase in 
average hydrodynamic radius comparable in shape to the heparin-induced oligomer 
formation in Figure 6.9.  However the mean radius increased significantly faster, 
reaching an Rh ≈ 69 nm after only 3 days (Fig 6.11).  Using AFM microscopy, we 
confirmed the presence of oligomeric aggregates with heights ranging from 15 to 20 
nanometers. 
 
 
 
Figure 6.11 Dynamic Light Scattering of Arachidonic Acid-Induced Tau Oligomer Growth at pH 
8.3 inhibited by the presence of Hsp90α and Hsp90β.  Tau mean radius monitored for 3 days in 
the absence (■) or presence of either Hsp90α (■), Hsp90β (■), or both Hsp90α and Hsp90β (■) at 
a molar ratio of 50 moles of tau to 1 mole of Hsp90α and/or Hsp90β.   
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Figure 6.12 Atomic Force Microscopy of Arachidonic Acid-Induced Tau Oligomer Aggregation 
at pH 8.3 in the presence of Hsp90’s. (A) AFM image of tau monomers before addition of 
arachidonic acid or incubation at 37°C. (B) AFM image of tau aggregation and the existence of 
oligomeric aggregates after 3 days of incubation at 37°C in the presence of arachidonic acid at a 
molar ratio of 4 tau : 1 arachidonic acid.  (C) AFM image of tau in the presence of Hsp90α after 3 
days of incubation under the same conditions as B. (D) AFM image of tau in the presence of 
Hsp90β after 3 days of incubation under the same conditions as B.  All images are 2μm x 2μm. 
 
 
 The presence of Hsp90α and/or Hsp90β, at molar ratio of Hsp90 to tau of 1:50, 
again inhibited the rate of the hydrodynamic radius increase with time.    After 3 days, tau 
in the presence of Hsp90α reached Rh ≈ 42 nm, tau in the presence of Hsp90β reached Rh 
≈ 53 nm, and tau in the presence of both Hsp90α and Hsp90β reached Rh ≈ 46 nm (Fig. 
6.11).  AFM microscopy indicated that the average aggregate size had indeed decreased 
but that the number of smaller oligomeric aggregates had increased compared to tau 
controls (Fig 6.12).   
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6.3.5 FKBP51wt and 51M(F130A) Reduce Hydrodynamic Size of Tau Oligomers  
 
Figure 6.13 Dynamic Light Scattering of Heparin-Induced Tau Oligomer Growth at pH 8.3 
inhibited by the presence of FKBP51wt and FKBP51M (F130A).  Tau mean radius monitored for 
8 days in the absence (■) or presence of either FKBP51wt (■), or FKBP51M (F130A) (■) at a 
molar ratio of 50 moles of tau to 1 mole of FKBP51wt or FKBP51M (F130A)   
  
 
 
Figure 6.14 Atomic Force Microscopy of Heparin-Induced Tau Oligomer Aggregation at pH 8.3 
in the presence of FKBP’s. (A) AFM image of tau monomers before addition of heparin or 
incubation at 37°C (B) AFM image of tau aggregation and the existence of oligomeric aggregates 
after 8 days of incubation at 37°C in the presence of heparin at a molar ratio of 4 tau : 1 heparin.  
(C) AFM image of tau in the presence of FKBP51wt after 8 days of incubation under the same 
conditions as B. (D) AFM image of tau in the presence of FKBP51M (F130A) after 8 days of 
incubation under the same conditions as B.  All images are 2μm x 2μm. 
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 We further characterized the effects of FKBP51wt and FKBP51M (F130A) alone 
for both heparin and arachidonic acid induced oligomeric growth of tau.  Under the 
heparin-inducing conditions, both the presence of FKBP51wt or FKBP51M (F130A) 
inhibited the increasing hydrodynamic radius of tau with time.  After 8 days, tau alone 
had a hydrodynamic radius of Rh ≈ 35.3 nm while tau in the presence of FKBP51wt had 
an Rh ≈ 22.5 nm and tau in the presence of FKBP51M (F130A) had an Rh ≈ 28.6 nm (Fig. 
6.13).  AFM microscopy revealed similar patterns as the Hsp90 variants: increasing 
numbers of smaller oligomeric aggregates in the presence of FKBP51wt or FKBP51M 
(F130A) (Fig 6.14).   
 
 
 
Figure 6.15 Dynamic Light Scattering of Arachidonic Acid-Induced Tau Oligomer Growth at pH 
8.3 inhibited by the presence of FKBP51wt and FKBP51M (F130A). Tau mean radius monitored 
for 3 days in the absence (■) or presence of either FKBP51wt (■), or FKBP51M (F130A) (■) at a 
molar ratio of 50 moles of tau to 1 mole of FKBP51wt or FKBP51M (F130A).   
  
 The arachidonic-acid induced oligomeric growth of tau in the presence of 
FKBP51wt or FKBP51M (F130A) showed similar behavior.  The presence of FKBP51wt 
or FKBP51M (F130A) inhibited the increasing hydrodynamic radius with time, although 
with different efficacy.  After 3 days, tau alone had a hydrodynamic radius of Rh ≈ 69 nm 
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while tau in the presence of FKBP51wt had an Rh ≈ 29.2 nm and tau in the presence of 
FKBP51M (F130A) had an Rh ≈ 44.1 nm (Fig. 6.15).  AFM microscopy indicated an 
increasing number of oligomeric aggregates in the 6 nm range (Fig 6.16) and also an 
increased population of yet smaller aggregates in the 3 nm range. 
 
 
Figure 6.16 Atomic Force Microscopy of Arachidonic Acid-Induced Tau Oligomer Aggregation 
at pH 8.3 in the presence of FKBP’s. (A) AFM image of tau monomers before addition of 
arachidonic acid or incubation at 37°C (B) AFM image of tau aggregation and the existence of 
oligomeric aggregates after 3 days of incubation at 37°C in the presence of arachidonic acid at a 
molar ratio of 4 tau : 1 arachidonic acid.  (C) AFM image of tau in the presence of FKBP51wt 
after 3 days of incubation under the same conditions as B (D) AFM image of tau in the presence 
of FKBP51M (F130A) after 3 days of incubation under the same conditions as B.  The larger 
images are 2μm x 2μm.  The insets are 250nm x 250nm and the height scale is 0 to 3 nm to 
enhance background aggregates. 
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6.3.6 FKBP51wt and FKBP51M (F130A) modulations are unaffected by the 
presence of Hsp90β and occasionally affected by Hsp90α during oligomer growth 
 We then investigated different combinations of Hsp90 and FKBP51 on oligomer 
growth.  Using the same oligomeric growth conditions as Sections 6.3.4 and 6.3.5, we 
found that the aggregation kinetics for tau in the presence of FKBP51wt was unaffected 
by addition of Hsp90β and was slightly retarded in the presence of Hsp90α under heparin 
conditions (Fig. 6.17).  Using arachidonic acid as an oligomer inducer, neither the 
presence of Hsp90α nor Hsp90β affected the kinetics of tau plus FKBP51wt aggregation 
(Fig. 6.18).  This trend persisted in the presence of the mutant version of FKBP51 as 
shown in Figure 6.19 and Figure 6.20. In the presence of heparin, FKBP51M (F130A) 
effects were essentially unaltered by the additional presence of either Hsp90α or Hsp90β, 
while Hsp90α in the presence of arachidonic acid, marginally enhanced the retardation of 
tau aggregation by FKBP51M.  
 
 
 
Figure 6.17 Dynamic Light Scattering of Heparin-Induced Tau Oligomer Growth at pH 8.3 in 
the presence of different combinations of FKBP51wt, Hsp90α, and Hsp90β.  (A) Tau mean radius 
monitored for 8 days in the absence (■) or presence of either 51wt (■), Hsp90α (■), or both 51wt 
and Hsp90α (■) at a molar ratio of 50 moles of tau to 1 mole of FKBP51wt and/or Hsp90α.  (B) 
Tau mean radius monitored for 8 days in the absence (■) or presence of either 51wt (■), Hsp90β 
(■), or both 51wt and Hsp90β (■) at a molar ratio of 50 moles of tau to 1 mole of FKBP51wt 
and/or Hsp90β.   
A B
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Figure 6.18 Dynamic Light Scattering of Arachidonic Acid-Induced Tau Oligomer Growth at pH 
8.3 in the presence of different combinations of FKBP51wt, Hsp90α, and Hsp90β.  (A) Tau mean 
radius monitored for 3 days in the absence (■) or presence of either 51wt (■), Hsp90α (■), or both 
51wt and Hsp90α (■) at a molar ratio of 50 moles of tau to 1 mole of FKBP51wt and/or Hsp90α.  
(B) Tau mean radius monitored for 3 days in the absence (■) or presence of either 51wt (■), 
Hsp90β (■), or both 51wt and Hsp90β (■) at a molar ratio of 50 moles of tau to 1 mole of 
FKBP51wt and/or Hsp90β.   
 
 
 
 
Figure 6.19 Dynamic Light Scattering of Heparin-Induced Tau Oligomer Growth at pH 8.3 in 
the presence of different combinations of FKBP51M (F130A), Hsp90α, and Hsp90β.  (A) Tau 
mean radius monitored for 8 days in the absence (■) or presence of either F130A (■), Hsp90α 
(■), or both F130A and Hsp90α (■) at a molar ratio of 50 moles of tau to 1 mole of F130A and/or 
Hsp90α.  (B)  Tau mean radius monitored for 8 days in the absence (■) or presence of either 
F130A (■), Hsp90β (■), or both F130A and Hsp90β (■) at a molar ratio of 50 moles of tau to 1 
mole of F130A and/or Hsp90β.   
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Figure 6.20 Dynamic Light Scattering of Heparin-Induced Tau Oligomer Growth at pH 8.3 in 
the presence of different combinations of FKBP51M (F130A), Hsp90α, and Hsp90β.  (A) Tau 
mean radius monitored for 3 days in the absence (■) or presence of either F130A (■), Hsp90α 
(■), or both F130A and Hsp90α (■) at a molar ratio of 50 moles of tau to 1 mole of F130A and/or 
Hsp90α.  (B)  Tau mean radius monitored for 3 days in the absence (■) or presence of either 
F130A (■), Hsp90β (■), or both F130A and Hsp90β (■) at a molar ratio of 50 moles of tau to 1 
mole of F130A and/or Hsp90β.   
 
 
6.4 Discussion 
 It has been shown that Hsp90 levels in vivo have an inverse correlation to granular 
tau levels and a direct correlation with soluble tau in human brain tissue.  In short, as 
Hsp90 levels increase, more soluble tau is extracted and less granular tau oligomers are 
found [17].  Our in vitro data support this relationship both under fibrillar and oligomeric 
growth conditions.  Under fibrillar growth conditions, the presence of Hsp90 decreased 
the number of oligomers as shown in the background of the AFM images (Fig 6.2) while 
under oligomeric conditions the size of the oligomers decreased even though the number 
of smaller aggregates increased (Fig. 6.10 and 6.12).  However, Hsp90α and Hsp90β had 
very different effects on tau fibril formation.  Under fibrillar conditions, Hsp90α 
enhanced the formation of fibrils while Hsp90β inhibited their formation.  Although, 
these results were puzzling, by investigating Hsp90 activity under oligomeric conditions, 
A B
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DLS data and AFM images revealed a greater efficiency for Hsp90α to prevent oligomer 
formation as compared to Hsp90β (Fig. 6.10 and 6.12).  These results may explain why 
tau in the presence of Hsp90α is driven to grow more fibrils and fewer oligomers even 
under fibril growing conditions.  Even though Hsp90α and Hsp90β have different 
structures, different binding affinities for tau, and different expression levels, many 
previous in vivo studies do not separate the activity of Hsp90α and Hsp90β.  This is 
especially important, given that Hsp90α and Hsp90β have different effects on in vitro tau 
aggregation implying there may be varying levels of cell toxicity for tau after interacting 
with Hsp90α or Hsp90β. 
 Previous studies have shown that co-chaperones of Hsp90 such as FKBP51 can 
interact with tau directly and effect tau processing.  Jinwal et al. (2010) showed that 
overexpression of FKBP51wt in HeLa cells increased phosphorylated tau and total tau 
levels by 80%, indicating that FKBP51wt PPIase activity may have a direct effect on 
enhancing tau phosphorylation and preventing tau degradation.  However, by generating 
a PPIase deficient mutant, Jinwal et al. (2010) also showed that FKBP51’s ability to 
phosphorylate tau was not abolished by a lack of PPIase activity but rather enhanced by 
hyperphosphorylation of tau at several important sites linked to resistance to degradation.  
Our in vitro data under oligomeric growth conditions supplement these observations.  
There the amount of tau aggregates was greatly increased by the presence of FKBP51. 
This suggests FKBP51 may be stabilizing tau into smaller more compact structures 
thereby enhancing the effective number and/or “stickiness” of smaller oligomers while 
preventing large oligomeric clusters to form.   Additionally, the PPIase deficient form 
FKBP51M (F130A) under arachidonic acid oligomeric growth conditions grew even 
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smaller structures as shown in Figure 6.16 which could be an indication of even further 
tau toxicity.   
 Lastly, our data on the combinations of Hsp90 and FKBP51 give insight into 
which chaperone may play the dominant role during tau binding.  Our in vitro results 
suggest that direct FKBP/tau interactions will likely dominate even in the presence of 
Hsp90α and Hsp90β.  Given Hsp90β is expressed constitutively at high levels and 
Hsp90α is the stress-inducible isoform, Hsp90β might serve more as a scaffolding protein 
for FKBP51 and tau to interact directly while Hsp90α assists in protein degradation more 
directly.  These results however are somewhat ambiguous since we did not measure 
binding affinities to determine the likelihood of forming a chaperone complex vs. the 
possibility that FKBP has an intrinsically greater affinity for tau than Hsp90.  Regardless, 
in the presence of both FKBP and Hsp90, it appears FKBP will play the dominant role. 
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Chapter 7 
 
Conclusion 
 
 Using a combination of biophysical approaches, including static and dynamic 
light scattering, atomic force microscopy and circular dichroism, we have studied several 
basic aspects of fibril formation by two distinctly different amyloidogenic proteins: hen 
egg white lysozyme and human recombinant tau.  Specifically, we investigated how the 
forces and structural characteristics among amyloid proteins affect their likelihood for 
self-assembly into amyloid fibrils.  Furthermore, we studied how tau interactions with the 
chaperone network can modulate tau aggregation.  These relationships are critical for 
understanding why proteins form amyloid fibers in vivo and for designing drugs to 
regulate this process. 
 We systematically investigated whether the assembly process for lysozyme 
changes as function of salt concentration.  These experiments revealed that lysozyme 
displayed three distinct aggregation regimes.  At the lowest salt concentrations, the onset 
of fibril assembly was delayed by many days.  More importantly, the eventual onset of 
aggregation resulted in the formation of two distinct populations of nuclei.  Using atomic 
force microscopy, we determined that nucleation under these conditions generated two 
distinct polymeric assemblies composed of monomers.  At intermediate salt 
concentrations (150mM to 300mM) in contrast, oligomeric intermediates began to form 
immediately.  These oligomers, and not the monomers, became the building blocks for 
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subsequent fibril assembly.  Lastly, we found that at high salt concentrations (> 350mM 
NaCl) fibril formation was replaced by the growth of unstructured precipitates.   
 These results characterized differences in the assembly pathways, but one of the 
basic questions of amyloid fibril growth is to unravel whether and how the forces among 
the proteins (intermolecular interaction) and the structure of the protein (intramolecular 
conformation) affect the assembly process.  Using circular dichroism to investigate 
protein conformation, we found no discernable differences in the protein conformation as 
a function of salt concentration. This suggested that our observed changes in the 
assembly pathway did not arise from changes to the molecular conformation of 
lysozyme.  Using static light scattering, we then measured the virial coefficients of 
lysozyme at different salt concentrations.  Virial coefficients are a measure of the 
character (attractive vs. repulsive) and strength of the intermolecular protein interactions.  
It turned out that net protein interactions during fibril assembly were repulsive, 
suggesting the somewhat counter-intuitive result that repulsion is necessary to permit 
ordered assembly of these partially denatured molecules. Precipitation, in contrast, 
coincided with the onset of net attraction. In addition, we found that the interactions 
among the partially unfolded proteins also differed during "monomeric" vs. "oligomeric" 
fibril assembly.  This suggests that protein interactions hold critical clues for 
understanding differences in amyloid fibril assembly pathways. 
 Another aspect of this dissertation research focused on the role of regulatory 
proteins, called chaperones.  These chaperones are important regulators for the proper 
folding of proteins and the "disposal" of proteins within cells.  In collaboration with Dr. 
Chad Dickey in the Department of Molecular Medicine and Pharmacology, we 
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investigated the role of the chaperones as modulators of tau fibril assembly.  Tau, 
typically abundant in the nervous system as a microtubule-associated protein, is involved 
in a number of neurodegenerative diseases, including Alzheimer’s disease and Pick’s 
disease.  Using our experimental approaches developed for lysozyme, we have shown 
that the small chaperone wtHsp27 is capable of inhibiting tau fibril growth both in vitro 
and in vivo.  We also investigated the role of two additional chaperones, Hsp90 and its 
associated FKBP51 binding partner.  We concluded that both chaperones at low 
stoichiometric ratios can modulate tau aggregation in vitro, however with different 
consequences and efficacy. 
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